WO2012081911A2 - Saliva purifying method - Google Patents

Saliva purifying method Download PDF

Info

Publication number
WO2012081911A2
WO2012081911A2 PCT/KR2011/009639 KR2011009639W WO2012081911A2 WO 2012081911 A2 WO2012081911 A2 WO 2012081911A2 KR 2011009639 W KR2011009639 W KR 2011009639W WO 2012081911 A2 WO2012081911 A2 WO 2012081911A2
Authority
WO
WIPO (PCT)
Prior art keywords
saliva
present
hormone
steroid
hormones
Prior art date
Application number
PCT/KR2011/009639
Other languages
French (fr)
Korean (ko)
Other versions
WO2012081911A3 (en
Inventor
박성대
Original Assignee
퍼팩트코리아(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020100127671A external-priority patent/KR20110068906A/en
Priority claimed from KR1020110133597A external-priority patent/KR101467371B1/en
Application filed by 퍼팩트코리아(주) filed Critical 퍼팩트코리아(주)
Publication of WO2012081911A2 publication Critical patent/WO2012081911A2/en
Publication of WO2012081911A3 publication Critical patent/WO2012081911A3/en

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40Concentrating samples
    • G01N1/4044Concentrating samples by chemical techniques; Digestion; Chemical decomposition

Definitions

  • the present invention relates to a method for removing substances other than hormones for the analysis of hormones in saliva, and more particularly, to a method for effectively purifying saliva through specific pH control and temperature control.
  • Analytical steroid hormones are composed of male hormone (androgen), female hormone (estrogen), progestin, corticosteroid (corticoid), which are synthesized by the action of various enzymes using cholesterol (cholesterol) as a precursor Sterols and the like.
  • Steroid hormones that control the endocrine system cause diseases when biological changes occur due to enzyme deficiency or excess of enzymes involved in their metabolism.
  • cholesterol cholesterol
  • saliva contains a very small amount of steroid hormones, if you can accurately analyze them, you can easily identify the adrenal and gonad functions, and get information on stress levels and sexual dysfunctions.
  • Saliva sampling is non-invasive, so it is possible to collect saliva without the help of medical staff in accordance with the daily rhythm of the individual (wake up to bed), so that the circulating rhythm of hormone production and secretion of the individual can be grasped.
  • has high clinical utility because it is composed of active hormones that act on tissues (Wood, 2009)
  • the concentration of steroids in saliva is as low as 1 / 100-1 / 1000 of the blood, it cannot be analyzed by commercially available hormone analysis kits.
  • Saliva contains digestive enzymes such as amylases, bacteria, mucosaccharides of slippery ingredients (Schenkels et al., 1995; Pogrel et al., 1997; Humphrey et al., 2001; Whembolua, et al., 2006 These substances can influence antigen-antibody responses during the quantitative analysis of steroid hormones in saliva by immunoassay (Tallon et al., 1985). In other words, various foreign substances, such as proteins, act as a factor of disturbance in the antigen-antibody reaction process, and thus show different results from the actual hormone levels, making accurate analysis very difficult.
  • the present inventors in order to accurately detect steroid hormones to be analyzed while effectively removing various substances contained in the collected saliva, increase the accuracy of steroid hormone detection through specific pH control and temperature control in addition to the conventional heat treatment method. It was confirmed that the present invention was completed.
  • An object of the present invention is to provide a method for purifying saliva for the analysis of hormones and the like in saliva.
  • the present invention provides a method for purifying saliva comprising the following steps:
  • the method of the present invention is a step of pretreatment of saliva for the quantitative analysis of steroid hormones such as sex hormones or corticosteroids present in saliva, and can accurately detect steroid hormones using radioimmunoassay after pretreatment of the present invention. have.
  • Saliva collection is preferably performed within 1 hour after the gas phase. For example, it may be collected immediately after the weather, 30 minutes after the weather and 1 hour after the weather, and used to analyze the change.
  • a strong base having a pH of 12 to 14 may be one selected from the group consisting of NaOH, LiOH, KOH, and Ca (OH) 2 . In one embodiment of the present invention 1N NaOH was used.
  • the heating in step (b) is preferably made of a temperature of 70 ⁇ 90 °C, more preferably about 80 °C.
  • the cooling may be performed by quenching using, for example, an ice bath.
  • step (b) it is preferable to further include the step of removing the denatured digestive enzymes and bacteria by pH and heat from saliva by centrifugation.
  • the (c) neutralization step is most typically carried out by treating a strong acid of pH 1-2, in particular, the strong acid of pH 1-2 is in the group consisting of HCl, H 2 SO 4 , HNO 3 It may be one selected. In one embodiment of the present invention 1N HCl was used.
  • step (d) the removal of mucus (mucosaccharides) is achieved by treating the mucus glycoprotein (mucosaccharide) degrading enzyme. Since the mucoglycoprotein (mucosaccharide) is not denatured by heat, a method of removing by using an enzyme is used.
  • the mucolytic enzyme can be any enzyme capable of degrading ⁇ -Nacetylhexosamine- [1 ⁇ 4] glycosidic bond, and in one embodiment of the present invention, hyaluronidase type 1 (H 3506, Sigmaaldrich). chemical co.) 500 IU was used.
  • mucoglycoprotein micosugar
  • the buffer solution preferably contains the same amount of gelatin as saliva. This gelatin leads to a homogeneous distribution of trace estradiol in saliva and maintains optimum acidity even when saliva is exposed to outside air during the analysis.
  • the present invention is characterized by using a process of denaturing protein in saliva using rapid temperature changes and pH changes in order to accurately measure the concentration of steroid hormones in saliva, such as estradiol, testosterone, cortisol and the like. By accurate analysis of hormone concentrations, it is possible to collect information necessary for diagnosing physiological activity of women and diagnosing stress.
  • the present invention relates to a method for purifying saliva by denaturing proteins contained in saliva through rapid temperature changes and pH changes.
  • the present invention is very useful because it can further increase the accuracy compared to the conventional saliva pretreatment method, it is possible to detect a small amount of hormones in saliva.
  • 1 is a graph showing the difference in absorbance (A280 nm) after saliva sample pretreatment by the method of the present invention in combination with the conventional heat treatment method and acidity (pH) change / mucosaccharide decomposition.
  • Figure 2 is a graph showing the difference in steroid recovery after saliva sample pretreatment by the method of the present invention in combination with the conventional heat treatment method and acidity (pH) change / mucosaccharide decomposition.
  • Subject refers to an animal, in some embodiments a mammal, and in other embodiments a human being to be treated, observed or tested. In particular, in the present invention, a human female was targeted.
  • sample or “sample” means a collection of similar cells obtained from a tissue of a subject or patient.
  • Sources of tissue or cell samples may include solid tissue from fresh, frozen and / or preserved organ or tissue samples or biopsies or aspirates; Blood or any liquid tissue.
  • saliva is used.
  • a steroid hormone is a hormone that has a steroid ring (cyclopentanohydrophenanthrene ring), a 4-membered ring hydrocarbon, as a basic structure. It is a male and female gonad hormone (sex hormone) found in higher animals and humans. ) And corticosteroids.
  • Gonadotropin or sex hormone is a hormone secreted from the gonads of females and males of vertebrates serves to promote the development of the genitals and maintain its function.
  • the gonads that secrete hormones are hepatocytes in the testes in males and the females are mainly follicles or corpus luteum in the ovaries.
  • the adrenal cortex secrete substances with the action of sex hormones.
  • sex hormones are also released from the placenta, contributing to the maintenance of pregnancy. All sex hormones are steroidal substances
  • the present invention relates to a pretreatment process necessary for the analysis of specific proteins, hormones, etc. present in saliva, and most preferably, it is possible to efficiently remove other substances except steroid hormones for steroid hormone analysis. It relates to a method for purifying saliva.
  • step (b) it is preferable to further include the step of removing the digestive enzymes and bacteria modified by pH and heat from the saliva by centrifugation, and after the step (d), mixing the buffer solution It is more preferable to carry out further.
  • the present invention relates to a pretreatment process for the use of "saliva" as analytical sample .
  • hormone concentrations were measured mainly in blood.
  • blood is not a hormone's target organ, but a simple hormone carrier.
  • Most blood protein hormones growth hormones, insulin, etc.
  • steroids produced in the adrenal cortex and gonads are insoluble in water and therefore combined with other media (carrier proteins).
  • Is present in the blood When steroids are combined with the carrier, they do not act on the hormone receptors in the target organs, so they are called 'inactive' and cannot induce physiological mechanisms.
  • Most of the steroids in the blood (95-99%) are present in this inactive state and only a fraction (1-4%) are known to be in an unbound state (active state). Therefore, the concentration of steroids in the blood can be said to be the concentration of most inactive rather than the concentration of the hormone in the active state.
  • the steroid contained in the saliva is not in an active state in which all of the steroids are bound to the carrier medium, and the active steroid contained in the extracelluar fluid is the salivary gland by passive diffusion. Will be moved to. Therefore, the steroid concentration contained in saliva is recognized as an active steroid contained in the tissue.
  • saliva unlike blood, can be easily collected by the general public in accordance with the individual's sleep cycle without the help of medical personnel, so it has the advantage of easily conducting research on the hormonal circadian rhythm of the individual. In other words, using saliva has the advantage of easy access to the concentration of active steroids and the hormonal circadian rhythms, which were difficult to access to blood.
  • the present invention relates to a method for purifying saliva that can be used for analysis using saliva as a sample, and the above advantages can be exhibited effectively.
  • Saliva collection can be done by spitting saliva into the collection tube and using salm that can penetrate the saliva.However, when collecting saliva using materials such as cotton, the steroid hormones contained in saliva The risk of quantitative concentrations differing from the actual amount of hormones may be due to combinations with the material or the effects of the material itself. Therefore, the preferred saliva collection method in the present invention is a method to spit saliva directly into the collection container.
  • the saliva samples are spited directly into the provided sampling tube at the moment of waking up in the morning (within 1 minute immediately after waking up), 30 minutes after waking up and 60 minutes after waking up, respectively. Can be harvested. At this time, brushing your teeth, smoking, drinking caffeine-containing beverages for one hour after waking up, and do not eat snacks or meals.
  • the present invention uses the principle of protein denaturation utilizing "pH control and abrupt temperature change", not the conventional heating method.
  • Protein denaturation means that proteins are affected by physical factors (heating, drying, stirring, pressure, X-rays, ultrasound, vibration, freezing), chemical factors (acids, bases, urea, organic solvents, heavy metals, surfactants) and enzymatic reactions. It refers to a phenomenon in which the unique higher-order structure (secondary, third-order, fourth-order) changes without changing the peptide structure. Among them, the temperature of the thermal denaturation is usually 60 ⁇ 70 °C in the protein and the higher the temperature, the faster the denaturation rate.
  • the strong base of pH 12-14 is not limited, but may be one strong base solution selected from the group consisting of NaOH, LiOH, KOH, Ca (OH) 2 , preferably about 1N concentration.
  • the saliva treated with the strong base is heated to a temperature of 70 ° C. to 90 ° C. for about 20 to 30 minutes, and then the temperature is rapidly lowered. In one embodiment of the present invention was heated for about 20 minutes at 80 °C and then quenched using an ice bath.
  • the present invention purifies saliva using the principle of protein denaturation through pH and rapid temperature changes, thereby making it possible to detect trace steroid hormones in saliva with high accuracy. That is, compared with the conventional heating and cooling process, the present invention is exposed to a high temperature of 20-30 minutes after the strong base treatment and quenched using an ice bath, so that the denatured protein does not have a problem of returning to its original structure. This has the effect of increasing the accuracy of hormone detection and reducing the analysis time.
  • centrifugation is performed to remove digestive enzymes, bacteria, and the like contained in saliva. At this time, it is preferably performed for about 15000 ⁇ 17000rpm, 3 ⁇ 5 °C, 5 ⁇ 10 minutes. For example, it is performed for 5 minutes at 4 °C at 16000 rpm.
  • a neutralization step of adjusting the pH to the neutral pH is performed.
  • the most representative method can be used to treat strong acid solutions of pH 1-2.
  • the strong acid having a pH of 1 to 2 may be used, for example, one selected from the group consisting of HCl, H 2 SO 4 , HNO 3 , and the like, and may be used at a concentration of about 1N.
  • the supernatant obtained after centrifugation is treated with a strong acid solution having a pH of 1 to 2 at a 1N concentration to adjust the neutral acidity (pH).
  • the obtained neutral sample is treated with a mucin glycoproteinase to remove mucus glycoprotein (mucosaccharide) in saliva.
  • mucin glycoproteinase since the mucin glycoprotein is not denatured by heat, it is highly likely that the above-described denaturation process alone will be an obstacle in obtaining accurate results in the subsequent hormonal analysis.
  • the mucus glycoprotein (mucosaccharide) is included with the step of decomposing using an enzyme.
  • Mucus is a biological liquid that can form a gel, which is a mixture of components that contain water and secretions of various cells. Mucins are also called mucus glycoproteins or epithelial glycoproteins, and a number of disaccharide side chains are linked by N- and O-links to the peptide core. It is a major component of the mucus and glycoconjugates that are characterized
  • mucoglycoprotein (mucosaccharide) is not denatured by heat, various mucolytic agents or mucoglycoproteinases that can directly degrade it are used.
  • the mucin glycoprotein (mucosaccharide) degrading enzyme of the present invention may be any enzyme capable of degrading ⁇ -Nacetylhexosamine- [1 ⁇ 4] glycosidic bond, and in one embodiment of the present invention, hyaluronidase type 1 (H 3506, Sigmaaldrich chemical co.) 500 IU was used.
  • mucolytic agents or mucin glycoproteinases can often be classified into the following groups: proteases that break down the protein core of mucin glycoproteins (Eg, pronase, papain); Sulfhydryl compounds that cleave mucoprotein disulfide linkages; And detergents that destroy non-covalent bonds in mucus (eg, Triton X-100, Tween 20). Additional compounds may be used in this context, but not limited to, bile salts and surfactants such as sodium deoxycholate, sodium taurodeoxycholate, sodium glycolate, and Lysophosphatidylcholine.
  • the mucus glycoproteinase is treated and reacted at about 37 ° C. for 10 to 15 minutes to break down the mucus glycoprotein in saliva.
  • the sample is heated again to a temperature of 70 ° C ⁇ 90 ° C, and then rapidly lowered to induce denaturation of the mucoglycoproteinase.
  • the sample was heated for about 10 minutes at 80 °C and then quenched using an ice bath. Thereafter, the denatured mucin glycoproteinase is removed by centrifugation.
  • the buffer preferably contains the same amount of gelatin as saliva.
  • the gelatin induces a homogeneous distribution of trace steroids, estradiol and maintains optimal acidity even when saliva is exposed to outside air during the analysis.
  • the saliva purification process of the present invention takes about 25 to 30 minutes for the strong base treatment, heating and quenching steps, and takes about 20 to 25 minutes for the removal of mucus glycoprotein (mucosugar) and the enzyme used therein, It takes 50 to 60 minutes. This has the effect of being much shorter in time compared to the conventional saliva purification process, which required heating at about 56 ° C. for at least 2 hours.
  • the greatest effect of the saliva purification process of the present invention is to bring high accuracy in the subsequent analysis of hormones and the like. That is, the present invention effectively removes impurities and other components other than steroid hormones present in trace amounts in saliva. This can be confirmed through the embodiment of the present invention.
  • the method of the present invention relates to a saliva pretreatment process for accurate analysis of a target protein contained in saliva, most preferably a steroid hormone such as sex hormone, corticosteroid, etc. Detect steroid hormones in an appropriate way. Examples include the following hormones.
  • “Sex hormones” express the development and function of male or female reproductive organs. In testes, testosterone is produced, and the name androgen is used according to its action. In the ovary, two steroid hormones are made. Mature follicle epithelium ⁇ ⁇ ) follicle hormone estradiol, the corpus luteum hormone progesterone is made. When they pay attention to the action, the names estrogen and gestagen are used respectively.
  • the "androgen” is, for example, dihydrotestosterone (DHT), dehydroepiandrosterone (DHEA), testosterone (testosterone), 5 ⁇ -androstan-3 ⁇ , 17 ⁇ -diol (5 ⁇ -androstane- 3 ⁇ , 17 ⁇ -diol, androstenedione, epipitosterone, 5 ⁇ -androstan-3 ⁇ , 17 ⁇ -diol, 5 ⁇ -androstane-3 ⁇ , 17 ⁇ -diol, androstenediol, andros Theronsterone, etiocholanolone, 11-keto-androsterone (11-keto-A), 11-keto-etiocholanolone: 11- keto-E), 11-hydroxy-androsterone (11-OH-A), 11-hydroxy-etiocholanolone (11-OH-E) and 5 ⁇ Androstanedione (5 ⁇ -androstanedione) and the like.
  • DHT
  • estrone 17 ⁇ -estradiol, estriol, 2-hydroxy-estrone (2-OH-E1), 2-hydrate.
  • 2-hydroxy-estradiol (2-OH-E2) 17-epiestriol
  • 4-hydroxy-estrone (4-OH-E1) 4-hydroxy-estradiol (4-OH-E2)
  • 2-methoxy-estrone 2-MeO-E1
  • 2-methoxy-estradiol 2-methoxy-estradiol
  • 16 ⁇ -hydroxy-estrone (16 ⁇ -hydroxy-estrone: 16 ⁇ -OH-E1), and the like.
  • cortinoids steroid hormones
  • aldosterone inorganic corticoid
  • corticosterone cortisol
  • cortisone saliva corticosteroid
  • the "adrenal cortex hormone" is triamcinolone, prednisolone, prednisone, prednisone, fluorochlorocortisone, 6 ⁇ -methylprednisolone, betamethasone, dexamethasone, dexamethasone, dexamethasone, dexamethasone, dexamethasone, and dexamethasone.
  • Flumethasone beclomethasone, triamcinolone acetonide, desonide, flunisolide, flurandrenolide, fluorinolone acetonide ( fluocinolone acetonide, desoximethasone, budesonide, flucinonide, amcinonide, cortisol and cortisone, and the like.
  • radioimmunoassay there is no limitation as a method for detecting such steroid hormones in the purified saliva sample, it is preferable to use radioimmunoassay.
  • EIA enzyme immunoassay
  • CIA chemiluminescence immunoassay
  • ABEI aminobutyl-ethylisoluminol
  • FIA fluorescent label Fluorescence immunoassay
  • Radioimmunoassays have many advantages, such as high sensitivity, precision, and accuracy, and allow for clear and clear detection after the reaction. Most preferably, radioimmunoassays can be used. For this purpose, a liquid-phased-double antibody method can be used. More detailed measurement procedures are available in the literature on hormone measurement using the liquid-dual antibody method (Salivary cortisol and DHEA levels in the Korean population; age-related differences, diurnal, and correlations with serum levels.Yonsei Med J. 2007; 48: 379 -88).
  • hormonal analyzes mainly use immunoassay using antigen-antibody reactions. Since various foreign substances act as disturbances in antigen-antibody reactions, they often show different results from actual hormone levels. By using the saliva sample purified by the various foreign substances such as this can be effectively removed, more accurate concentration measurement is possible.
  • Steroid hormone in saliva is very low level, but the saliva purified by the method of the present invention significantly increases the detection efficiency of the hormone, it can be accurately measured using radioimmunoassay.
  • the saliva sample was checked for the purpose of treatment, menstrual cycle, menopause and timing, and weight, height and body mass index were measured.
  • women taking hormone replacement therapy, oral contraceptives, drugs containing tamoxifen or estrogen, and progesterone cortisol Women who have been diagnosed with abnormalities in pregnancy, lactation, infertility, sexually transmitted diseases or ovarian function; Women with severe disease such as cancer, diabetes, high / low blood pressure or abnormal body mass index (BMI ⁇ 18 or ⁇ 25) were excluded.
  • Women included in the screening were asked to spit 1 ml of saliva samples directly into the provided collection tubes each time they woke up in the morning (less than 1 minute after waking up), 30 minutes after waking up and 60 minutes after waking up.
  • women included in the screening were not allowed to brush their teeth, smoke, drink intake of caffeine and eat snacks or meals for 1 hour after waking up, and the saliva collection time was marked on the surface of the collecting tube using an oil pen. .
  • Cortisol produced and secreted by the adrenal gland has a very pronounced circadian rhythm, especially at 30 minutes immediately after waking up.
  • saliva is not collected immediately after the weather, there is no difference from the cortisol concentration measured in the saliva 30 minutes after the weather.
  • These results should be at least 2.8 nmol / L, which means that saliva was collected immediately after the weather. Therefore, after cortisol was quantitatively analyzed in the saliva of women included in the screening, only samples with a difference of more than 2.8 nmol / L were selected from samples taken immediately after the weather and 30 minutes after the weather.
  • sexual function is affected by internal and external stress factors, samples that are considered to have a shift in adrenal function due to extremely low or high cortisol concentration were excluded from screening.
  • saliva each treated with 1N NaOH was heated at 80 ° C. for about 20 minutes and then quenched using an ice bath. Then, centrifugation was performed to remove digestive enzymes, bacteria, and the like contained in saliva. The supernatant was then collected and treated with 1N HCl to adjust the pH to neutral acidity.
  • the mucosaccharide degrading enzyme hyaluronidase type 1 (H 3506, Sigmaaldrich chemical co.) 500 IU was treated and reacted at about 37 ° C. for 10 minutes to decompose the mucus glycoprotein (mucosaccharide) in saliva.
  • the sample was heated at 80 ° C. for about 10 minutes and then quenched using an ice bath. Thereafter, the denatured mucin glycoproteinase was removed by centrifugation.
  • the process took about 1 hour and 30 minutes in total.
  • centrifugation of sputum and foreign substances in saliva was carried out in accordance with the existing method of saliva pretreatment (Howard et al., 1989; Tamate et al., 1997). 10 minutes) After removal, the saliva sample was heated at 56 ° C. for 2 hours, and then allowed to stand at room temperature (25 ° C.) for 10 minutes, followed by centrifugation (3000 g, 20 minutes) to obtain a supernatant. (About 3 hours). Absorbance at 280 nm (A280) was measured using a spectrophotometer (Beckman DU 800 UV / VIS).
  • Saliva samples treated with the method of the present invention of Example 1 were also measured for absorbance at 280 nm (A280) using a spectrophotometer (Beckman DU 800 UV / VIS).
  • a pretreated saliva sample was used as a control.
  • the absorbance of the untreated saliva sample was 0.05664 0.0002 and the absorbance of the previously treated saliva sample was 0.3794 0.0006.
  • the absorbance of the saliva sample pretreated with the method of the present invention was 0.0361 00003.
  • both the conventional method and the method of the present invention have the effect of removing protein-based material contained in saliva, and the difference in protein-based material removal effect between the two methods is not significant.
  • Comparative Example 2 Comparison of Steroid Hormone Loss Rate in Pretreatment by Conventional Heat Treatment and Pretreatment According to the Present Invention
  • saliva sample When the saliva sample is pretreated by heating at 56 ° C (2 hours) and centrifuged (conventional method) and when the saliva sample is pretreated using a combination of acidity (pH) / mucosaccharide decomposition (method of the invention) Pretreatment of the saliva sample
  • saliva samples were added with 5000 cpm of steroid hormones (cortisol, testosterone, estradiol) labeled with radioisotopes, and then the recovery rate of steroid hormones was examined.
  • steroid hormones were detected by radioimmunoassay to find out whether the conventional method and the method of the present invention have no significant difference in the amount of protein change or steroid loss rate. .
  • the saliva sample was first centrifuged (3000 g, 10 minutes) to remove the sputum component first, and the supernatant was taken.
  • Dextrane-coated activated carbon (dextran coated 0.1% activated charcoal (w / v)) in the supernatant was stirred for 12 hours in a low temperature chamber maintained at 4 ° C to remove small molecular weight substances such as steroid hormones contained in saliva samples. (charcoal stripped saliva, CSS).
  • the RIA method confirmed that the CSS contained residual steroid hormones.
  • the CSS did not contain cortisol and sex hormones (below detection range).
  • Known concentration in CSS Pretreatment of saliva samples by the conventional method and the method of the present invention is carried out by adding cortisol (500 pg / 100 ul), testosterone (50 pg / 100 ul) and estradiol (50 pg / 100 ul), respectively. Each of these steroid hormones was then quantified in saliva samples.
  • steroid hormones were detected slightly higher than expected in saliva samples that were not pretreated. This is interpreted as the effect that the high molecular weight substances (proteins, mucosaccharides, etc.) that could not be removed by activated carbon contained in the saliva sample interfered with the antigen-antibody reaction in hormonal quantitative analysis.
  • the method of the present invention improves the accuracy of the detection concentration.
  • the present invention is a technique that improves the accuracy of hormone extraction without the difference between the change in protein amount and steroid hormone loss rate.

Abstract

The present invention relates to a method which denatures proteins contained in the saliva by suddenly varying a temperature and pH, to thereby purify the saliva. Particularly, the method of the present invention has higher accuracy compared to conventional saliva pre-treatment methods, and thus enables very small amount of hormone in the saliva to be detected, and is therefore very useful. That is, the method of the present invention may be valuably used in a pre-treatment process for a variety of analyses which use saliva as a sample.

Description

타액 정제 방법 Saliva Purification Method
본 발명은 타액 내 호르몬 등의 분석을 위해 호르몬 외에 여타 필요없는 물질들을 제거하는 방법에 관한 것으로, 보다 구체적으로는 특정 pH 조절 및 온도 조절을 통해 효과적으로 타액을 정제하는 방법에 관한 것이다.The present invention relates to a method for removing substances other than hormones for the analysis of hormones in saliva, and more particularly, to a method for effectively purifying saliva through specific pH control and temperature control.
분석 대상물질인 스테로이드 호르몬들은 콜레스테롤(cholesterol)을 전구물질로 하여 다양한 효소의 작용를 통해 합성되어지는 남성호르몬(androgen), 여성호르몬(estrogen), 황체호르몬(progestin), 부신피질호르몬(corticoid), 그리고 스테롤(sterol)등을 포함한다. 내분비계를 조절하는 스테로이드 호르몬은 그들의 대사에 관여하는 효소의 결핍(enzyme deficiency) 또는 과잉(excess)등에 의한 생물학적 변화가 생기면 질환이 발생하게 되는데, 최근 특정 생리, 병리적 상태에서 관련 스테로이드 호르몬의 변화를 분석한 후 이것을 생리적 기능과 연관 지어 해석함으로써 질환 발병의 원인을 규명하는 연구가 활발히 진행되고 있다.Analytical steroid hormones are composed of male hormone (androgen), female hormone (estrogen), progestin, corticosteroid (corticoid), which are synthesized by the action of various enzymes using cholesterol (cholesterol) as a precursor Sterols and the like. Steroid hormones that control the endocrine system cause diseases when biological changes occur due to enzyme deficiency or excess of enzymes involved in their metabolism. Recently, changes in related steroid hormones in certain physiological and pathological conditions After analyzing the results and interpreting them in relation to physiological functions, studies are being actively conducted to investigate the causes of disease development.
다양한 스테로이드 호르몬을 평가하기 위한 분석법이 광범위하게 개발되고 있으며[Endo. J., 2003, 50: 783-792], 이를 통해 1) 활성이 높은 스테로이드들간의 상대적 변화 측정, 2) 대사 경로 상에서의 전구물질과 생성물질 간 대사균형의 변화 규명, 3) 대사 경로 상에서 나타나는 불균형으로부터 이에 관련된 효소의 활성도 등을 측정함으로써 질환에 따른 내인성 물질들의 변화된 대사 과정을 종합적으로 평가할 수 있다.Assays for evaluating various steroid hormones have been extensively developed [Endo. J., 2003, 50: 783-792], whereby 1) measuring relative changes between highly active steroids, 2) identifying changes in metabolic balance between precursors and products on metabolic pathways, and 3) appearing on metabolic pathways. By measuring the activity of enzymes related thereto from the imbalance, it is possible to comprehensively evaluate the metabolic processes of endogenous substances according to disease.
타액 내에 극 미량의 스테로이드 호르몬들이 포함되어 있으므로, 이들을 정확히 분석할 수 있으면 손쉽게 부신 및 생식소 기능을 파악하고 스트레스 정도, 성기능 이상 등에 대한 정보를 얻을 수 있다. Since saliva contains a very small amount of steroid hormones, if you can accurately analyze them, you can easily identify the adrenal and gonad functions, and get information on stress levels and sexual dysfunctions.
타액채취는 비 침습적이기 때문에 개인의 하루 주기리듬 (기상~취침)에 맞추어 의료진의 도움없이도 타액 채취가 가능하여 개인의 호르몬생성, 분비의 일주기리듬을 파악할 수있고 아울러 타액에 포함되어 있는 스테로이드 호르몬은 조직에 작용하는 활성형의 호르몬으로 구성되어 있기 때문에 임상적 활용도가 높다 (Wood, 2009) Saliva sampling is non-invasive, so it is possible to collect saliva without the help of medical staff in accordance with the daily rhythm of the individual (wake up to bed), so that the circulating rhythm of hormone production and secretion of the individual can be grasped. Has high clinical utility because it is composed of active hormones that act on tissues (Wood, 2009)
그러나 타액에 포함되어 있는 스테로이드 농도는 혈액의 1/100-1/1000 정도로 낮기 때문에 상용화된 호르몬 분석키트로는 분석이 불가능하며 세계적으로도 몇 군데 실험실에서만 측정하고 있다. However, because the concentration of steroids in saliva is as low as 1 / 100-1 / 1000 of the blood, it cannot be analyzed by commercially available hormone analysis kits.
타액 내에는 아밀라제 등 소화효소, 박테리아, 미끈거리는 성분의 뮤코당등이 포함되어 있고(Schenkels et al., 1995; Pogrel et al., 1997; Humphrey et al., 2001; Whembolua, et al., 2006), 이들 물질은 타액내에 포함되어 있는 스테로이드 호르몬을 면역측정법을 이용하여 정량분석하는 과정 중, 항원-항체 반응에 영향을 미쳐 호르몬 수치의 변화를 유도할 수 있다 (Tallon et al., 1985). 즉, 단백질 등 다양한 이물질은 항원-항체 반응과정에 교란의 요인으로 작용하여 실제 호르몬 수치와 다른 결과를 나타내므로 정확한 분석이 매우 어렵다.Saliva contains digestive enzymes such as amylases, bacteria, mucosaccharides of slippery ingredients (Schenkels et al., 1995; Pogrel et al., 1997; Humphrey et al., 2001; Whembolua, et al., 2006 These substances can influence antigen-antibody responses during the quantitative analysis of steroid hormones in saliva by immunoassay (Tallon et al., 1985). In other words, various foreign substances, such as proteins, act as a factor of disturbance in the antigen-antibody reaction process, and thus show different results from the actual hormone levels, making accurate analysis very difficult.
따라서, 타액시료를 임상적 목적의 호르몬 분석에 이용할 수 있기 위해서는 면역측정법에 적합하도록 정확성(accuracy)과 반복성(repoductivity)을 갖춘 전처리 공정이 필수적이다. 종래에는 타액을 2시간 정도 56℃에서 열처리한 후 타액에 포함되어 있는 스테로이드 호르몬을 분석하였지만 (Howard et al., 1989; Tamate et al., 1997), 그 정확성에 있어서 신뢰성을 갖기 어려웠다. Therefore, in order for saliva samples to be used for hormonal analysis for clinical purposes, a pretreatment process with accuracy and repoductivity is essential for immunoassay. Conventionally, after saliva was heat treated at 56 ° C. for 2 hours, steroid hormones contained in saliva were analyzed (Howard et al., 1989; Tamate et al., 1997), but it was difficult to have reliability in accuracy.
이에 본 발명자는, 채취한 타액에 포함되어 있는 여러가지 물질들을 효과적으로 제거하면서 분석하고자 하는 스테로이드 호르몬 등을 정확히 검출하기 위해서는 종래의 열처리 방법에서 벗어나 특정 pH 조절 및 온도 조절을 통해 스테로이드 호르몬 검출의 정확성을 높일 수 있음을 확인하고 본 발명을 완성하였다.Accordingly, the present inventors, in order to accurately detect steroid hormones to be analyzed while effectively removing various substances contained in the collected saliva, increase the accuracy of steroid hormone detection through specific pH control and temperature control in addition to the conventional heat treatment method. It was confirmed that the present invention was completed.
본 발명의 목적은 타액 내 호르몬 등의 분석을 위해, 타액을 정제하는 방법을 제공하는 데 있다.An object of the present invention is to provide a method for purifying saliva for the analysis of hormones and the like in saliva.
상기 과제를 해결하기 위하여, 본 발명은 다음의 단계를 포함하는 타액을 정제하는 방법을 제공한다:In order to solve the above problems, the present invention provides a method for purifying saliva comprising the following steps:
(a) 채취한 타액에 pH 12~14의 강염기를 처리하는 단계;(a) treating the collected saliva with a strong base of pH 12-14;
(b) 가열 후 냉각시키는 단계; (b) cooling after heating;
(c) 중화 단계; 및(c) neutralization step; And
(d) 점액당단백질(뮤코당) 제거단계.(d) mucus glycoprotein (mucosugar) removal step.
특히 본 발명의 방법은 타액 내 존재하는 성호르몬 또는 부신피질 호르몬 등의 스테로이드 호르몬의 정량분석을 위해 타액을 전처리하는 공정으로서, 본 발명의 전처리 후 방사면역측정법을 이용하여 스테로이드 호르몬을 정확히 검출할 수 있다.In particular, the method of the present invention is a step of pretreatment of saliva for the quantitative analysis of steroid hormones such as sex hormones or corticosteroids present in saliva, and can accurately detect steroid hormones using radioimmunoassay after pretreatment of the present invention. have.
타액의 채취는 기상 후 1시간 이내에 이루어지는 것이 바람직하다. 예를 들어, 기상 직후, 기상 후 30분 및 기상 후 1시간별로 채취하여 그 변화 등을 분석하는데 사용될 수 있다.Saliva collection is preferably performed within 1 hour after the gas phase. For example, it may be collected immediately after the weather, 30 minutes after the weather and 1 hour after the weather, and used to analyze the change.
(a)단계에서 pH 12~14의 강염기는 NaOH, LiOH, KOH, Ca(OH)2 로 구성된 군에서 선택되는 1종일 수 있다. 본 발명의 일 실시예에서는 1N NaOH를 사용하였다.In step (a), a strong base having a pH of 12 to 14 may be one selected from the group consisting of NaOH, LiOH, KOH, and Ca (OH) 2 . In one embodiment of the present invention 1N NaOH was used.
또한, 상기 (b)단계에서 가열은 70~90℃의 온도로 이루어지는 것이 바람직하고, 더욱 바람직하게는 약 80℃이다. 그리고, 상기 냉각은 예를 들어, 얼음수조를 이용하여 급냉시키는 것에 의해 수행될 수 있다.In addition, the heating in step (b) is preferably made of a temperature of 70 ~ 90 ℃, more preferably about 80 ℃. In addition, the cooling may be performed by quenching using, for example, an ice bath.
그리고, 상기 (b) 단계 후, 원심분리에 의해 타액으로부터 pH 및 열에 의하여 변성된 소화효소 및 박테리아를 제거하는 단계를 추가로 포함하는 것이 바람직하다.And, after the step (b), it is preferable to further include the step of removing the denatured digestive enzymes and bacteria by pH and heat from saliva by centrifugation.
또한, 상기 (c) 중화단계는 pH 1~2의 강산을 처리하는 것에 의해 수행되는 것이 가장 대표적인데, 특히, 상기 pH 1~2의 강산은 HCl, H2SO4, HNO3로 구성된 군에서 선택되는 1종일 수 있다. 본 발명의 일 실시예에서는 1N HCl을 사용하였다.In addition, the (c) neutralization step is most typically carried out by treating a strong acid of pH 1-2, in particular, the strong acid of pH 1-2 is in the group consisting of HCl, H 2 SO 4 , HNO 3 It may be one selected. In one embodiment of the present invention 1N HCl was used.
또한, 상기 (d) 단계에서 점액질(뮤코당) 제거는 점액당단백질(뮤코당) 분해효소를 처리하는 것에 의해 이루어진다. 상기 점액당단백질(뮤코당)은 열에 의해 변성되지 않기 때문에 효소를 이용하여 제거하는 방법을 사용하는 것이다.In addition, in step (d), the removal of mucus (mucosaccharides) is achieved by treating the mucus glycoprotein (mucosaccharide) degrading enzyme. Since the mucoglycoprotein (mucosaccharide) is not denatured by heat, a method of removing by using an enzyme is used.
이 때, 상기 점액질(뮤코당) 분해효소는 β-Nacetylhexosamine-[1→4] glycosidic bond을 분해할 수 있는 효소면 어느 것이나 가능하며, 본 발명의 일 실시예에서는 hyaluronidase type 1 (H 3506, Sigmaaldrich chemical co.) 500 IU를 사용하였다.At this time, the mucolytic enzyme can be any enzyme capable of degrading β-Nacetylhexosamine- [1 → 4] glycosidic bond, and in one embodiment of the present invention, hyaluronidase type 1 (H 3506, Sigmaaldrich). chemical co.) 500 IU was used.
그리고, 점액당단백질(뮤코당) 제거 후, 원심분리에 의해 점액당단백질(뮤코당) 분해효소를 제거하는 단계를 추가로 수행하는 것이 더욱 바람직하다.Further, after removing the mucoglycoprotein (mucosugar), it is more preferable to perform the step of removing the mucoglycoprotein (mucosaccharide) degrading enzyme by centrifugation.
마지막으로, 완충액을 혼합하는 단계를 추가로 수행함으로써, 타액 정제공정을 마무리할 수 있다. 이 때, 상기 완충액은 타액과 동일양의 젤라틴을 포함하는 것이 바람직하다. 이러한 젤라틴은 타액 내 미량의 에스트라디올이 균질하게 분포하도록 유도하고 타액이 분석과정 중 외부 공기에 노출되더라도 최적의 산도를 유지하도록 한다. Finally, by further performing the step of mixing the buffer, it is possible to finish the saliva purification process. At this time, the buffer solution preferably contains the same amount of gelatin as saliva. This gelatin leads to a homogeneous distribution of trace estradiol in saliva and maintains optimum acidity even when saliva is exposed to outside air during the analysis.
본 발명은 타액 내 스테로이드 호르몬, 예를 들어 에스트라디올, 테스토스테론, 코티졸 등의 농도를 정확히 측정하기 위해, 급속한 온도 변화 및 pH 변화를 이용하여 타액 내 단백질을 변성시키는 공정을 이용함을 특징으로 하고 있다. 이러한 정확한 호르몬의 농도분석에 의해 여성의 생리활성 진단, 스트레스 진단 등에 필요한 정보를 수집할 수 있다.The present invention is characterized by using a process of denaturing protein in saliva using rapid temperature changes and pH changes in order to accurately measure the concentration of steroid hormones in saliva, such as estradiol, testosterone, cortisol and the like. By accurate analysis of hormone concentrations, it is possible to collect information necessary for diagnosing physiological activity of women and diagnosing stress.
본 발명은 급속한 온도 변화 및 pH 변화를 통해 타액 내에 포함되어 있는 단백질을 변성시켜 타액을 정제하는 방법에 관한 것이다. 특히, 본 발명은 종래의 타액 전처리 방법과 비교하여 그 정확성을 더욱 높일 수 있어, 타액 내 미량의 호르몬을 검출할 수 있게 하므로 매우 유용하다.The present invention relates to a method for purifying saliva by denaturing proteins contained in saliva through rapid temperature changes and pH changes. In particular, the present invention is very useful because it can further increase the accuracy compared to the conventional saliva pretreatment method, it is possible to detect a small amount of hormones in saliva.
도 1은 종래 열처리 방법 및 산도 (pH) 변화/뮤코당분해를 병행한 본 발명의 방법으로 타액시료 전처리 후 흡광도 (A280nm)의 차이를 나타낸 그래프이다.1 is a graph showing the difference in absorbance (A280 nm) after saliva sample pretreatment by the method of the present invention in combination with the conventional heat treatment method and acidity (pH) change / mucosaccharide decomposition.
도 2는 종래 열처리 방법 및 산도 (pH) 변화/뮤코당분해를 병행한 본 발명의 방법으로 타액시료 전처리 후 스테로이드 회수율의 차이를 나타낸 그래프이다.Figure 2 is a graph showing the difference in steroid recovery after saliva sample pretreatment by the method of the present invention in combination with the conventional heat treatment method and acidity (pH) change / mucosaccharide decomposition.
본 발명에서 사용되는 용어에 대한 정의는 이하와 같다.Definitions of terms used in the present invention are as follows.
"대상" 또는 "개체"는 동물, 몇몇 구체예에서는 포유동물, 그리고 다른 구체예에서는 치료, 관찰 또는 실험 대상인 인간을 의미하는 것이다. 특히, 본 발명에서는 인간 여성을 대상으로 하였다."Subject" or "subject" refers to an animal, in some embodiments a mammal, and in other embodiments a human being to be treated, observed or tested. In particular, in the present invention, a human female was targeted.
"시료" 또는 "샘플"은 대상 또는 환자의 조직으로부터 얻은 유사한 세포의 집합체를 의미한다. 조직 또는 세포 샘플의 공급원은 신선한, 동결된 및/또는 보존된 장기 또는 조직 샘플 또는 생검 또는 흡인물로부터의 고형 조직; 혈액 또는 임의의 액형 조직일 수 있다. 본 발명에서는 타액(saliva)을 사용한다."Sample" or "sample" means a collection of similar cells obtained from a tissue of a subject or patient. Sources of tissue or cell samples may include solid tissue from fresh, frozen and / or preserved organ or tissue samples or biopsies or aspirates; Blood or any liquid tissue. In the present invention, saliva is used.
"스테로이드호르몬(steroid hormone)"이란 4원자고리 탄화수소인 스테로이드 고리(사이클로펜타노하이드로페난트렌 고리)를 기본 구조로 가진 호르몬으로, 고등동물이나 사람에게서 볼 수 있는 웅성·자성의 생식선 호르몬(성호르몬)이나 부신피질 호르몬 등이 포함된다.A steroid hormone is a hormone that has a steroid ring (cyclopentanohydrophenanthrene ring), a 4-membered ring hydrocarbon, as a basic structure. It is a male and female gonad hormone (sex hormone) found in higher animals and humans. ) And corticosteroids.
"생식선 호르몬 또는 성호르몬"이란 척추동물의 암컷·수컷의 생식선에서 분비되는 호르몬으로 생식기의 발육을 촉진시키고 그 기능을 유지시키는 역할을 한다. 호르몬을 분비하는 생식선은 웅성의 경우는 정소 중의 간세포(間細胞)이고 자성은 주로 난소(卵巢) 중의 여포나 황체이다. 생식선뿐만 아니라 부신피질로부터도 성호르몬의 작용을 갖는 물질이 분비된다. 또, 임신 중에는 태반으로부터도 성호르몬이 분비되어 임신유지에 기여한다. 성호르몬은 모두 스테로이드계 물질이다"Gonadotropin or sex hormone" is a hormone secreted from the gonads of females and males of vertebrates serves to promote the development of the genitals and maintain its function. The gonads that secrete hormones are hepatocytes in the testes in males and the females are mainly follicles or corpus luteum in the ovaries. Not only the gonads but also the adrenal cortex secrete substances with the action of sex hormones. During pregnancy, sex hormones are also released from the placenta, contributing to the maintenance of pregnancy. All sex hormones are steroidal substances
본 명세서에서 사용되는 정도의 용어 "약", "실질적으로" 등은 언급된 의미에 고유한 제조 및 물질 허용오차가 제시될 때 그 수치에서 또는 그 수치에 근접한 의미로 사용되고, 본 발명의 이해를 돕기 위해 정확하거나 절대적인 수치가 언급된 개시 내용을 비양심적인 침해자가 부당하게 이용하는 것을 방지하기 위해 사용된다.As used herein, the terms "about", "substantially", and the like, are used at, or in close proximity to, numerical values when manufacturing and material tolerances inherent in the meanings indicated are intended to aid the understanding of the invention. Accurate or absolute figures are used to assist in the prevention of unfair use by unscrupulous infringers.
본 발명에서 사용되는 모든 기술용어는, 달리 정의되지 않는 이상, 본 발명의 관련 분야에서 통상의 당업자가 일반적으로 이해하는 바와 같은 의미로 사용된다. 또한 본 명세서에는 바람직한 방법이나 시료가 기재되나, 이와 유사하거나 동등한 것들도 본 발명의 범주에 포함된다. 본 명세서에 참고문헌으로 기재되는 모든 간행물의 내용은 본 발명에 도입된다.All technical terms used in the present invention, unless defined otherwise, are used in the meaning as commonly understood by those skilled in the art in the related field of the present invention. Also described herein are preferred methods or samples, but similar or equivalent ones are within the scope of the present invention. The contents of all publications described herein by reference are incorporated into the present invention.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 일 관점에서, 타액 속에 존재하는 특정 단백질, 호르몬 등의 분석을 위해 필요한 전처리 공정에 관한 것으로, 가장 바람직하게는 스테로이드 호르몬 분석을 위해 스테로이드 호르몬을 제외한 여타 다른 물질들을 효율적으로 제거할 수 있는 타액 정제방법에 관한 것이다.In one aspect, the present invention relates to a pretreatment process necessary for the analysis of specific proteins, hormones, etc. present in saliva, and most preferably, it is possible to efficiently remove other substances except steroid hormones for steroid hormone analysis. It relates to a method for purifying saliva.
본 발명의 일 구체예로서, 다음의 단계를 포함할 수 있다:In one embodiment of the present invention, the following steps may be included:
(a) 채취한 타액에 pH 12~14의 강염기를 처리하는 단계;(a) treating the collected saliva with a strong base of pH 12-14;
(b) 가열 후 냉각시키는 단계; (b) cooling after heating;
(c) 중화 단계; 및(c) neutralization step; And
(d) 점액당단백질(뮤코당) 제거단계.(d) mucus glycoprotein (mucosugar) removal step.
이 때, 상기 (b)단계 이후, 원심분리에 의해 타액으로부터 pH 및 열에 의하여 변성된 소화효소 및 박테리아를 제거하는 단계를 추가로 포함하는 것이 바람직하고, (d)단계 후, 완충액을 혼합하는 단계를 추가로 수행하는 것이 더욱 바람직하다.At this time, after the step (b), it is preferable to further include the step of removing the digestive enzymes and bacteria modified by pH and heat from the saliva by centrifugation, and after the step (d), mixing the buffer solution It is more preferable to carry out further.
상기 각 공정을 중심으로 이하 보다 상세히 설명한다.The following will focus on each of the above steps in more detail.
본 발명은 분석 시료로 "타액(saliva)"을 사용하는 경우를 위한 전처리 공정에 관한 것이다. The present invention relates to a pretreatment process for the use of "saliva" as analytical sample .
그 동안 호르몬의 농도는 혈액에서 주로 측정하였다. 내분비학 관점에서 보면 혈액은 호르몬의 표적기관이 아니라 단순한 호르몬의 이동매체이다. 대부분의 혈중 단백질계열 호르몬 (성장호르몬, 인슐린 등)은 물에 잘 용해되며 혈중에서는 활성화된 형태로 존재하지만 부신피질, 성선에서 생성되는 스테로이드는 물에 잘 녹지 않기 때문에 다른 매체 (운반단백질)와 결합하여 혈중에 존재한다. 스테로이드가 운반매체와 결합되어 있을 때는 표적기관의 호르몬 수용체에 작용하지 못하기 때문에 '불활성 상태'라 하며 생리적인 기작을 유도할 수 없다. 혈중 스테로이드 대부분(95-99%)은 이러한 불활성 상태로 존재하며 극히 일부 (1-4%)만 운반매체와 결합되어있지 않은 상태(활성상태)로 존재하는 것으로 알려져 있다. 따라서 혈중 스테로이드의 농도는 활성 상태의 호르몬의 농도라기보다는 대부분 불활성 상태의 농도라 할 수 있다. In the meantime, hormone concentrations were measured mainly in blood. From an endocrinology point of view, blood is not a hormone's target organ, but a simple hormone carrier. Most blood protein hormones (growth hormones, insulin, etc.) are well soluble in water and present in an activated form in the blood, but steroids produced in the adrenal cortex and gonads are insoluble in water and therefore combined with other media (carrier proteins). Is present in the blood. When steroids are combined with the carrier, they do not act on the hormone receptors in the target organs, so they are called 'inactive' and cannot induce physiological mechanisms. Most of the steroids in the blood (95-99%) are present in this inactive state and only a fraction (1-4%) are known to be in an unbound state (active state). Therefore, the concentration of steroids in the blood can be said to be the concentration of most inactive rather than the concentration of the hormone in the active state.
이에 반하여, 타액에 포함되어 있는 스테로이드는 혈액과 달리 모두 운반매체와 결합되어 있지 않은 활성 상태이며 조직외액(extracelluar fluid)에 포함되어 있는 활성상태의 스테로이드가 단순 확산방식(passive diffusion)에 의해 타액샘으로 이동한 것 이다. 따라서 타액에 포함되어 있는 스테로이드 농도는 조직 안에 포함되어 있는 활성상태의 스테로이드로 인식되고 있다.On the contrary, unlike the blood, the steroid contained in the saliva is not in an active state in which all of the steroids are bound to the carrier medium, and the active steroid contained in the extracelluar fluid is the salivary gland by passive diffusion. Will be moved to. Therefore, the steroid concentration contained in saliva is recognized as an active steroid contained in the tissue.
또한, 타액은 혈액과 달리 의료진의 도움 없이도 개인의 수면주기에 맞추어 일반인이 쉽게 채취할 수 있기 때문에 개인의 호르몬 하루주기 리듬에 대한 연구를 쉽게 진행할 수 있는 장점을 가지고 있다. 즉, 타액을 이용할 경우 혈액으로 접근이 어려웠던 활성상태의 스테로이드의 농도와 개인의 호르몬 하루주기 리듬에 대한 접근이 용이하다는 장점이 있다.In addition, saliva, unlike blood, can be easily collected by the general public in accordance with the individual's sleep cycle without the help of medical personnel, so it has the advantage of easily conducting research on the hormonal circadian rhythm of the individual. In other words, using saliva has the advantage of easy access to the concentration of active steroids and the hormonal circadian rhythms, which were difficult to access to blood.
본 발명은 타액을 시료로 하는 분석에 사용할 수 있는 타액 정제 방법에 관한 것인 바, 상기와 같은 장점을 효과로 발휘할 수 있다.The present invention relates to a method for purifying saliva that can be used for analysis using saliva as a sample, and the above advantages can be exhibited effectively.
타액채취는 집적 채취용 시험관에 타액을 뱉는 방법과 타액이 잘 스며들 수 있는 솜 등을 이용하는 방법이 있으나, 솜 등의 소재를 이용하여 타액을 채취할 경우 타액에 포함되어 있는 스테로이드 호르몬이 이들 소재와 결합하거나 소재 자체의 영향으로 실제 호르몬의 양과 다른 농도로 정량될 위험이 있다. 그러므로, 본 발명에서 바람직한 타액 채취 방법은 직접 타액을 채취용기에 뱉도록 하는 방법이다.Saliva collection can be done by spitting saliva into the collection tube and using salm that can penetrate the saliva.However, when collecting saliva using materials such as cotton, the steroid hormones contained in saliva The risk of quantitative concentrations differing from the actual amount of hormones may be due to combinations with the material or the effects of the material itself. Therefore, the preferred saliva collection method in the present invention is a method to spit saliva directly into the collection container.
특히, 스테로이드 호르몬 중에서 성호르몬의 분석을 위해서는, 바람직하게는 아침에 잠에서 깨는 순간(기상직후, 1분이내), 기상 후 30분, 기상 후 60분별로 각각 타액 시료를 제공된 채취용 튜브에 직접 뱉도록 하여 채취할 수 있다. 이 때, 기상 후 1시간 동안 양치질, 흡연, 카페인이 포함되어 있는 음료 섭취 및 간식이나 식사를 하지 않는 것이 좋다. In particular, for the analysis of sex hormones among steroid hormones, the saliva samples are spited directly into the provided sampling tube at the moment of waking up in the morning (within 1 minute immediately after waking up), 30 minutes after waking up and 60 minutes after waking up, respectively. Can be harvested. At this time, brushing your teeth, smoking, drinking caffeine-containing beverages for one hour after waking up, and do not eat snacks or meals.
타액에 포함되어 있는 미량의 호르몬 농도를 측정하기 위하여 본 발명은 종래의 가열 방법이 아니라, "pH 조절 및 급격한 온도변화"를 활용한 단백질 변성원리를 이용한다In order to measure trace hormone concentrations contained in saliva, the present invention uses the principle of protein denaturation utilizing "pH control and abrupt temperature change", not the conventional heating method.
일반적인 타액 정제공정에서는 열처리로 약 60 ℃에서 2시간 동안 가열하고 식힌 후, 원심분리하고 바로 분석을 행한다(Howard et al., 1989; Tamate et al., 1997) 그러나, 온도에 의해 변성된 단백질은 온도가 서서히 내려갈 때, 원 상태로 돌아가는 성질이 있고 원래 상태로 돌아가면 원심분리로 분리가 어려워지는 문제점이 있다.In a typical saliva purification process, heat treatment is performed at about 60 ° C. for 2 hours, followed by cooling, followed by centrifugation and direct analysis (Howard et al., 1989; Tamate et al., 1997). When the temperature is gradually lowered, there is a property to return to the original state and there is a problem that the separation is difficult by centrifugation.
단백질 변성이란 단백질이 물리적 요인(가열, 건조, 교반, 압력, X-선, 초음파, 진동, 동결), 화학적 요인(산, 염기, 요소, 유기용매, 중금속, 계면활성제) 및 효소작용 등에 의해 1차 구조(peptide structure)의 변화없이 특유의 고차구조(2차, 3차, 4차)가 변하는 현상을 일컫는다. 이 중에서, 열변성의 온도는 대개의 단백질에서 60∼70℃이며 온도가 높아질수록 변성속도는 빨라진다. Protein denaturation means that proteins are affected by physical factors (heating, drying, stirring, pressure, X-rays, ultrasound, vibration, freezing), chemical factors (acids, bases, urea, organic solvents, heavy metals, surfactants) and enzymatic reactions. It refers to a phenomenon in which the unique higher-order structure (secondary, third-order, fourth-order) changes without changing the peptide structure. Among them, the temperature of the thermal denaturation is usually 60 ~ 70 ℃ in the protein and the higher the temperature, the faster the denaturation rate.
더구나, 타액에 포함되어 있는 스테로이드 농도는 혈액의 1/100-1/1000 정도로 매우 낮기 때문에, 상용화된 호르몬 분석 키트로는 단백질 열변성의 불확실성 및 스테로이드 호르몬의 극미량으로 정확한 분석이 쉽지 않았다.In addition, since the concentration of steroids in saliva is very low, such as 1 / 100-1 / 1000 of the blood, accurate analysis was not easy due to the uncertainty of protein heat denaturation and trace amounts of steroid hormones.
그러나, 본 발명에서는 강염기 처리 후 20~30분의 단시간의 고열에 노출·급냉시킴으로써 보다 효과적으로 단백질을 변성시키는 방법을 이용하여 원심분리시 정확성을 높이게 된다.However, in the present invention, by using a method of denaturing proteins more effectively by exposing and quenching to a high heat for a short time of 20-30 minutes after the strong base treatment, the accuracy during centrifugation is increased.
보다 구체적으로 설명하면, 우선 채취한 타액에 pH 12~14의 강염기를 처리한다. 상기 pH 12~14의 강염기는 제한은 없으나, NaOH, LiOH, KOH, Ca(OH)2 로 구성된 군에서 선택되는 1종의 강염기 용액일 수 있으며, 약 1N 농도인 것이 바람직하다.More specifically, first, the saliva is treated with a strong base of pH 12-14. The strong base of pH 12-14 is not limited, but may be one strong base solution selected from the group consisting of NaOH, LiOH, KOH, Ca (OH) 2 , preferably about 1N concentration.
다음으로, 강염기를 처리한 타액을 약 20분 내지 30분 동안 70℃~90℃의 온도로 가열한 후, 급속히 온도를 낮춘다. 본 발명의 일 실시예에서는 80℃에서 약 20분동안 가열한 다음 얼음수조를 이용하여 급냉각시켰다.Next, the saliva treated with the strong base is heated to a temperature of 70 ° C. to 90 ° C. for about 20 to 30 minutes, and then the temperature is rapidly lowered. In one embodiment of the present invention was heated for about 20 minutes at 80 ℃ and then quenched using an ice bath.
이와 같이, 본 발명은 pH 및 급격한 온도 변화를 통한 단백질 변성 원리를 이용하여 타액을 정제함으로써, 타액 내 미량의 스테로이드 호르몬을 높은 정확성으로 검출가능하게 한다. 즉, 종래 가열 후 냉각공정과 비교하여, 본 발명은 강염기 처리 후 20~30분의 단시간의 고열에 노출시키고 얼음 수조 등을 이용하여 급냉시키기 때문에 변성된 단백질이 다시 원래 구조로 돌아가려는 문제점이 없는 것이고, 이를 통해 호르몬 검출의 정확성을 높이고, 분석 시간을 단축시키는 효과를 가지는 것이다.As such, the present invention purifies saliva using the principle of protein denaturation through pH and rapid temperature changes, thereby making it possible to detect trace steroid hormones in saliva with high accuracy. That is, compared with the conventional heating and cooling process, the present invention is exposed to a high temperature of 20-30 minutes after the strong base treatment and quenched using an ice bath, so that the denatured protein does not have a problem of returning to its original structure. This has the effect of increasing the accuracy of hormone detection and reducing the analysis time.
본 발명에서, 상기과 같은 가열 및 급냉 공정 후, 타액에 포함되어 있는 소화효소, 박테리아 등을 제거하기 위해 원심분리를 수행한다. 이 때, 약 15000~17000rpm, 3~5℃, 5~10분 동안 수행하는 것이 바람직하다. 예를 들어, 16000rpm으로 4℃에서 5분 동안 수행한다.In the present invention, after the heating and quenching process as described above, centrifugation is performed to remove digestive enzymes, bacteria, and the like contained in saliva. At this time, it is preferably performed for about 15000 ~ 17000rpm, 3 ~ 5 ℃, 5 ~ 10 minutes. For example, it is performed for 5 minutes at 4 ℃ at 16000 rpm.
다음으로, 본 발명에서는 염기성을 나타내고 있는 상기 시료에 대하여 중성 pH로 맞추는 중화단계를 수행한다. Next, in the present invention, a neutralization step of adjusting the pH to the neutral pH is performed.
가장 대표적으로 사용할 수 있는 방법은 pH 1~2의 강산 용액을 처리하는 것이다. pH 1~2의 강산은 예를 들어, HCl, H2SO4, HNO3 등으로 구성된 군에서 선택되는 1종을 사용할 수 있으며, 약 1N 농도로 사용할 수 있다.The most representative method can be used to treat strong acid solutions of pH 1-2. The strong acid having a pH of 1 to 2 may be used, for example, one selected from the group consisting of HCl, H 2 SO 4 , HNO 3 , and the like, and may be used at a concentration of about 1N.
바람직하게는, 원심분리 후 수득한 상층액에 대하여 1N 농도로 pH 1~2의 강산 용액을 처리하여 중성 산도(pH)를 맞춘다.Preferably, the supernatant obtained after centrifugation is treated with a strong acid solution having a pH of 1 to 2 at a 1N concentration to adjust the neutral acidity (pH).
그리고,상기 수득한 중성 시료에 대하여 점액당단백질 분해효소를 처리하여 타액 내의 점액당단백질(뮤코당)을 제거한다. 특히, 일한 점액당단백질은 열에 의해 변성되지 않기 때문에, 상기 설명한 변성공정만으로는 추후 호르몬 분석에 있어서 정확한 결과를 도출하는데 장애 요소가 될 가능성이 높다. The obtained neutral sample is treated with a mucin glycoproteinase to remove mucus glycoprotein (mucosaccharide) in saliva. In particular, since the mucin glycoprotein is not denatured by heat, it is highly likely that the above-described denaturation process alone will be an obstacle in obtaining accurate results in the subsequent hormonal analysis.
따라서, 본 발명에서는 이러한 점액당단백질(뮤코당)을 효소를 이용하여 분해시키는 공정을 함께 포함하는 것이다.Therefore, in the present invention, the mucus glycoprotein (mucosaccharide) is included with the step of decomposing using an enzyme.
점액(mucus)은 겔을 형성할 수 있는 생물학적 액체로, 물과 다양한 세포의 분비산물을 포함하는 성분들의 혼합물이다. 또한, 뮤신(mucin)은 점액당단백질(mucus glycoprotein) 또는 상피당단백질(epithelialglycoprotein)로 불리우며, 다수의 이당류 측쇄(side chain)가 펩티드 중심(core)에 N- 및 O- 결합으로 연결되어 있는 것으로 특정지워지는 점액과 당복합물(glycoconjugate)의 주 구성성분이다Mucus is a biological liquid that can form a gel, which is a mixture of components that contain water and secretions of various cells. Mucins are also called mucus glycoproteins or epithelial glycoproteins, and a number of disaccharide side chains are linked by N- and O-links to the peptide core. It is a major component of the mucus and glycoconjugates that are characterized
상기 점액당단백질(뮤코당)은 열에 의해 변성되지 않기 때문에 직접 이를 분해할 수 있는 다양한 점액분해제들 또는 점액당단백질 분해효소들을 사용한다.Since the mucoglycoprotein (mucosaccharide) is not denatured by heat, various mucolytic agents or mucoglycoproteinases that can directly degrade it are used.
본 발명의 점액당단백질(뮤코당) 분해효소는 β-Nacetylhexosamine-[1→4] glycosidic bond을 분해할 수 있는 효소면 어느 것이나 가능하며, 본 발명의 일 실시예에서는 hyaluronidase type 1 (H 3506, Sigmaaldrich chemical co.) 500 IU를 사용하였다.The mucin glycoprotein (mucosaccharide) degrading enzyme of the present invention may be any enzyme capable of degrading β-Nacetylhexosamine- [1 → 4] glycosidic bond, and in one embodiment of the present invention, hyaluronidase type 1 (H 3506, Sigmaaldrich chemical co.) 500 IU was used.
뿐만 아니라, 점액당단백질 분해효소의 작용의 기전들에 근거하여, 점액분해제들 또는 점액당단백질 분해효소들은 흔히 다음에 오는 그룹들로 분류될 수 있다 : 뮤신 당단백질들의 단백질 중심부를 분해시키는 프로테아제들 (예를 들면, 프로나아제(pronase), 파파인(papain)); 점액당단백질(mucoprotein) 이황화 연결들(disulfide linkages)을 쪼개는 설프히드릴 화합물들 ; 그리고 점액질 내에서 비공유 결합들을 파괴시키는 세척제들 (예를 들면, 트리톤 엑스-100, 트윈 20). 추가적인 화합물들은 이러한 맥락에서, 거기에 국한되지는 않으나, 담즙산염과 계면 활성제들, 예를 들면, 소듐 데옥시콜레이트(sodium deoxycholate), 소듐 타우로데옥시콜레이트(sodium taurodeoxycholate), 소듐 글리콜레이트, 그리고 리소포스파티딜 콜린(lysophosphatidylcholine)을 포함한다. In addition, based on the mechanisms of action of mucin glycoproteinases, mucolytic agents or mucin glycoproteinases can often be classified into the following groups: proteases that break down the protein core of mucin glycoproteins (Eg, pronase, papain); Sulfhydryl compounds that cleave mucoprotein disulfide linkages; And detergents that destroy non-covalent bonds in mucus (eg, Triton X-100, Tween 20). Additional compounds may be used in this context, but not limited to, bile salts and surfactants such as sodium deoxycholate, sodium taurodeoxycholate, sodium glycolate, and Lysophosphatidylcholine.
본 발명에서는 상기 점액당단백질 분해효소를 처리하고 약 37℃ 에서 10~15분 동안 반응시켜 타액 내의 점액당단백질을 분해한다.In the present invention, the mucus glycoproteinase is treated and reacted at about 37 ° C. for 10 to 15 minutes to break down the mucus glycoprotein in saliva.
그리고, 앞의 공정과 유사하게, 상기 시료를 70℃~90℃의 온도로 다시 가열한 후, 급속히 온도를 낮추어 상기 점액당단백질 분해효소의 변성을 유도한다. 본 발명의 일 실시예에서는 80℃에서 약 10분동안 가열한 다음 얼음수조를 이용하여 급냉각시켰다. 그 후, 원심분리에 의해 상기 변성된 점액당단백질 분해효소를 제거한다.And, similarly to the previous step, the sample is heated again to a temperature of 70 ° C ~ 90 ° C, and then rapidly lowered to induce denaturation of the mucoglycoproteinase. In one embodiment of the present invention was heated for about 10 minutes at 80 ℃ and then quenched using an ice bath. Thereafter, the denatured mucin glycoproteinase is removed by centrifugation.
마지막으로, 상기 수득된 시료에 완충액을 섞어 타액 정제과정을 마무리하는 것이 바람직하다.Finally, it is preferable to finish the saliva purification process by mixing the buffer with the obtained sample.
특히, 상기 완충액은 타액과 동일양의 젤라틴을 포함하는 것이 바람직하다. 상기 젤라틴은 미량의 스테로이드, 에스트라디올이 균질하게 분포하도록 유도하고 타액이 분석과정 중 외부 공기에 노출되더라도 최적의 산도를 유지하도록 한다. In particular, the buffer preferably contains the same amount of gelatin as saliva. The gelatin induces a homogeneous distribution of trace steroids, estradiol and maintains optimal acidity even when saliva is exposed to outside air during the analysis.
본 발명의 타액 정제 공정은 강염기 처리, 가열 및 급냉 단계에 약 25분 ~30분이 소요되고, 점액당단백질(뮤코당) 제거 및 여기에 사용된 효소 제거에 약 20분 ~25분이 소요되므로, 총 50분 ~ 60분의 시간이 소요된다. 이는 약 56℃로 2시간 이상의 가열이 필요했던 종래의 타액 정제 공정과 비교하여 시간적으로 훨씬 단축되는 효과가 있다.The saliva purification process of the present invention takes about 25 to 30 minutes for the strong base treatment, heating and quenching steps, and takes about 20 to 25 minutes for the removal of mucus glycoprotein (mucosugar) and the enzyme used therein, It takes 50 to 60 minutes. This has the effect of being much shorter in time compared to the conventional saliva purification process, which required heating at about 56 ° C. for at least 2 hours.
또한, 본 발명이 타액 정제공정의 가장 큰 효과는 이후 호르몬 등의 분석에 높은 정확성을 가져다 주는 것이다. 즉, 본 발명은 타액 내 미량으로 존재하고 있는 스테로이드 호르몬 외의 불순물 및 여타 성분들을 효과적으로 제거한다. 이는 본 발명의 실시예를 통해 확인할 수 있다. In addition, the greatest effect of the saliva purification process of the present invention is to bring high accuracy in the subsequent analysis of hormones and the like. That is, the present invention effectively removes impurities and other components other than steroid hormones present in trace amounts in saliva. This can be confirmed through the embodiment of the present invention.
본 발명의 방법은 타액 내 함유되어 있는 목적 단백질, 가장 바람직하게는 스테로이드 호르몬, 예를 들어 성 호르몬, 부신피질 호르몬 등의 정확한 분석을 위한 타액 전처리 공정에 관한 것이므로, 본 발명의 방법 수행 후, 이어서 스테로이드 호르몬을 적절한 방법으로 검출한다. 이하와 같은 호르몬을 예로 들 수 있다.Since the method of the present invention relates to a saliva pretreatment process for accurate analysis of a target protein contained in saliva, most preferably a steroid hormone such as sex hormone, corticosteroid, etc. Detect steroid hormones in an appropriate way. Examples include the following hormones.
"성호르몬"은 웅성 또는 자성 생식기관의 발달 및 그 기능을 발현시킨다. 정소에서는 테스토스테론이 만들어지는데, 그 작용에 따라 안드로겐이라는 이름이 사용된다. 난소에서는 2종의 스테로이드 호르몬이 만들어진다. 즉, 성숙여포상피(成熟
Figure f984
胞上皮)에서는 여포 호르몬인 에스트라디올, 황체에서는 황체 호르몬인 프로게스테론이 만들어진다. 이것들은 그 작용에 주목하는 경우에는 각각 에스트로겐·게스타겐이라는 이름이 사용된다
"Sex hormones" express the development and function of male or female reproductive organs. In testes, testosterone is produced, and the name androgen is used according to its action. In the ovary, two steroid hormones are made. Mature follicle epithelium
Figure f984
胞 上皮) follicle hormone estradiol, the corpus luteum hormone progesterone is made. When they pay attention to the action, the names estrogen and gestagen are used respectively.
상기 "안드로겐"은, 예를 들어, 디히드로테스토스테론(dihydrotestosterone,DHT), 디히드로에피안드로스테론(dehydroepiandrosterone, DHEA), 테스토스테론(testosterone), 5α-안드로스탄-3α,17β-디올(5α-androstane-3α,17β-diol), 안드로스텐디온(androstenedione), 에피테스토스테론(epitestosterone), 5α-안드로스탄-3β,17β-디올(5α-androstane-3β,17β-diol), 안드로스텐디올(androstenediol), 안드로스테론(androsterone), 에티오콜아놀론(etiocholanolone), 11-케토-안드로스테론(11-keto-androsterone: 11-keto-A), 11-케토-에티오콜아놀론(11-keto-etiocholanolone: 11-keto-E), 11-히드록시-안드로스테론(11-hydroxy-androsterone: 11-OH-A), 11-히드록시-에티오콜아놀론(11-hydroxy-etiocholanolone:11-OH-E) 및 5α-안드로스탄디온(5α-androstanedione) 등을 포함한다.The "androgen" is, for example, dihydrotestosterone (DHT), dehydroepiandrosterone (DHEA), testosterone (testosterone), 5α-androstan-3α, 17β-diol (5α-androstane- 3α, 17β-diol, androstenedione, epipitosterone, 5α-androstan-3β, 17β-diol, 5α-androstane-3β, 17β-diol, androstenediol, andros Theronsterone, etiocholanolone, 11-keto-androsterone (11-keto-A), 11-keto-etiocholanolone: 11- keto-E), 11-hydroxy-androsterone (11-OH-A), 11-hydroxy-etiocholanolone (11-OH-E) and 5α Androstanedione (5α-androstanedione) and the like.
상기 "에스트로겐"은 에스트론(estrone), 17β-에스트라디올(17β-estradiol), 에스트리올(estriol), 2-히드록시-에스트론(2-hydroxy-estrone: 2-OH-E1), 2-히드록시-에스트라디올(2-hydroxy-estradiol: 2-OH-E2), 17-에피에스트리올(17-epiestriol), 4-히드록시-에스트론(4-hydroxy-estrone: 4-OH-E1), 4-히드록시-에스트라디올(4-hydroxy-estradiol: 4-OH-E2), 2-메톡시-에스트론(2-methoxy-estrone: 2-MeO-E1), 2-메톡시-에스트라디올(2-methoxy-estradiol: 2-MeO-E2) 및 16α-히드록시-에스트론(16α-hydroxy-estrone: 16α-OH-E1) 등을 포함한다.The "estrogens" include estrone, 17β-estradiol, estriol, 2-hydroxy-estrone (2-OH-E1), 2-hydrate. 2-hydroxy-estradiol (2-OH-E2), 17-epiestriol, 4-hydroxy-estrone (4-OH-E1), 4-hydroxy-estradiol (4-OH-E2), 2-methoxy-estrone (2-MeO-E1), 2-methoxy-estradiol (2 -methoxy-estradiol: 2-MeO-E2), 16α-hydroxy-estrone (16α-hydroxy-estrone: 16α-OH-E1), and the like.
또한, 부신피질에서는 코르티노이드라고 총칭하는 스테로이드 호르몬(부신피질 호르몬)이 만들어진다. 이것들은 모두 생명유지에 불가결한 것이며, 그 중에서도 중요한 것은 알도스테론(무기질 코르티코이드), 코르티코스테론·코르티솔·코르티손(당질 코르티코이드) 등이 있다.In addition, in the adrenal cortex, steroid hormones (adrenal cortex hormones), collectively called cortinoids, are produced. These are all indispensable for life support, and among them, aldosterone (inorganic corticoid), corticosterone, cortisol and cortisone (sugar corticosteroid) are important.
상기 "부신피질호르몬"은 트리암시놀론(triamcinolone), 프레드니솔론(prednisolone), 프레드니손(prednisone), 플루오클로로코르티손(fluochlorocortisone), 6α-메틸프레드니솔론(6α-methylprednisolone), 베타메타손(betamethasone), 덱사메타손(dexamethasone), 플루메타손(flumethasone), 베크로메타손(beclomethasone), 트리암시놀론 아세토나이드(triamcinolone acetonide), 데소나이드(desonide), 플루니솔라이드(flunisolide), 플루르안드레놀라이드(flurandrenolide), 플루오시놀론 아세토나이드(fluocinolone acetonide), 데스옥소메타손(desoximethasone),부데소나이드(budesonide), 플루시노나이드( flucinonide), 암시노나이드(amcinonide), 코르티졸(cortisol) 및 코르티손(cortisone) 등을 포함한다.The "adrenal cortex hormone" is triamcinolone, prednisolone, prednisone, prednisone, fluorochlorocortisone, 6α-methylprednisolone, betamethasone, dexamethasone, dexamethasone, dexamethasone, dexamethasone, dexamethasone, and dexamethasone. Flumethasone, beclomethasone, triamcinolone acetonide, desonide, flunisolide, flurandrenolide, fluorinolone acetonide ( fluocinolone acetonide, desoximethasone, budesonide, flucinonide, amcinonide, cortisol and cortisone, and the like.
한편, 정제된 타액 시료에서 상기와 같은 스테로이드 호르몬 검출하기 위한 방법으로는, 제한은 없으나, 방사선 면역 측정법을 이용하는 것이 바람직하다.On the other hand, there is no limitation as a method for detecting such steroid hormones in the purified saliva sample, it is preferable to use radioimmunoassay.
예를 들어, 효소를 표지자로 이용한 효소면역측정법(EIA), luminol이나 그 유도체 또는 aminobutyl-ethylisoluminol(ABEI)로 감도를 증가시킨 화학섬광면역측정법(chemiluminescence immunoassay; CIA), 또는 형광물질표지자(fluorescent label)를 이용한 형광면역측정법(fluorescence immunoassay; FIA) 등이 사용될 수 있고, 특히, 방사면역측정법을 사용하는 것이 좋다.For example, enzyme immunoassay (EIA) using enzymes as markers, chemiluminescence immunoassay (CIA) with increased sensitivity with luminol or derivatives thereof or aminobutyl-ethylisoluminol (ABEI), or fluorescent label (fluorescent label) Fluorescence immunoassay (FIA) and the like can be used, and in particular, it is preferable to use radioimmunoassay.
방사면역측정법은 높은 감도(sensitivity)와 정밀도(precision), 정확도(accuracy)를 나타내며, 반응 후의 분명하고 명백한 검출을 가능케 해주는 등 여러 이점을 가지고 있는 바, 가장 바람직하게는 방사선 면역 측정법을 사용할 수 있고, 이를 위해 액상-이중 항체(liquid-phased-double antibody)방법을 이용할 수 있다. 보다 상세한 측정과정은 액상-이중항체 방법을 이용한 호르몬 측정에 관한 논문(Salivary cortisol and DHEA levels in the Korean population; age-related differences, diurnal,and correlations with serum levels. Yonsei Med J. 2007;48:379-88)을 참조할 수 있다. Radioimmunoassays have many advantages, such as high sensitivity, precision, and accuracy, and allow for clear and clear detection after the reaction. Most preferably, radioimmunoassays can be used. For this purpose, a liquid-phased-double antibody method can be used. More detailed measurement procedures are available in the literature on hormone measurement using the liquid-dual antibody method (Salivary cortisol and DHEA levels in the Korean population; age-related differences, diurnal, and correlations with serum levels.Yonsei Med J. 2007; 48: 379 -88).
대부분의 호르몬 분석은 주로 항원-항체 반응을 이용한 면역 측정법을 이용하는데, 다양한 이물질이 항원-항체 반응과정에 교란의 요인으로 작용하여 실제 호르몬 수치와 다른 결과를 나타내는 경우가 많으므로, 본 발명의 방법으로 정제된 타액 시료를 이용하면 이와같은 다양한 이물질이 효과적으로 제거되어 있는 바, 보다 정확한 농도측정이 가능하다.Most hormonal analyzes mainly use immunoassay using antigen-antibody reactions. Since various foreign substances act as disturbances in antigen-antibody reactions, they often show different results from actual hormone levels. By using the saliva sample purified by the various foreign substances such as this can be effectively removed, more accurate concentration measurement is possible.
타액 중의 스테로이드 호르몬은 매우 낮은 수준이지만 본 발명의 방법으로 정제된 타액은 상기 호르몬의 검출효율을 현저히 높여주기 때문에, 방사면역측정법 등을 이용하여 정확히 측정할 수 있다. Steroid hormone in saliva is very low level, but the saliva purified by the method of the present invention significantly increases the detection efficiency of the hormone, it can be accurately measured using radioimmunoassay.
[실시예] EXAMPLE
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. Hereinafter, the present invention will be described in more detail with reference to Examples.
이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.These examples are only for illustrating the present invention, it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as being limited by these examples.
실시예 1 : 타액 정제Example 1: Saliva Tablets
타액을 채취하는 대상은 치료목적의 의약품 복용력, 생리주기, 폐경여부 및 시기 등을 확인하였고 몸무게와 키, 체질량지수를 측정하였다. 대상여성 중 최근 3개월 동안 지속적으로 정상적인 생리주기를 가진 여성과 최근 1년전에 지속적으로 정상적인 생리주기가 없는 폐경기 여성을 대상으로 포함시켰다. The saliva sample was checked for the purpose of treatment, menstrual cycle, menopause and timing, and weight, height and body mass index were measured. We included women with normal menstrual cycles for the last 3 months and menopausal women without normal menstrual cycles a year ago.
그러나, 호르몬 대체요법, 경구 피임약 복용, tamoxifen 혹은 에스트로젠, 프로제스테론 코티졸이 포함되어 있는 약물을 복용하고 있는 여성; 임신중, 수유중, 불임판정, 성병 혹은 난소기능에 이상이 있다고 판정 받은 여성; 암, 당뇨, 고/저혈압등의 심각한 질환이 있거나 체질량지수가 비정상 (BMI ≤18 or ≥25)인 여성은 제외하였다. However, women taking hormone replacement therapy, oral contraceptives, drugs containing tamoxifen or estrogen, and progesterone cortisol; Women who have been diagnosed with abnormalities in pregnancy, lactation, infertility, sexually transmitted diseases or ovarian function; Women with severe disease such as cancer, diabetes, high / low blood pressure or abnormal body mass index (BMI ≤18 or ≥25) were excluded.
스크리닝 대상에 포함된 여성들에게 아침에 잠에서 깨는 순간(기상직후, 1분이내), 기상 후 30분, 기상 후 60분별로 각각 1ml의 타액 시료를 제공된 채취용 튜브에 직접 뱉도록 하였다. Women included in the screening were asked to spit 1 ml of saliva samples directly into the provided collection tubes each time they woke up in the morning (less than 1 minute after waking up), 30 minutes after waking up and 60 minutes after waking up.
여기서, 스크리닝 대상에 포함된 여성은 기상 후 1시간 동안 양치질, 흡연, 카페인이 포함되어 있는 음료수 섭취 및 간식이나 식사를 하지 않도록 하였으며, 타액 채취시간을 채취용 튜브표면에 유성펜을 이용하여 표기하도록 하였다. Here, women included in the screening were not allowed to brush their teeth, smoke, drink intake of caffeine and eat snacks or meals for 1 hour after waking up, and the saliva collection time was marked on the surface of the collecting tube using an oil pen. .
부신에서 생성, 분비되는 코티졸은 매우 뚜렷한 일주기 리듬을 보이며 특히 기상직후 30분에 하루중 최고의 농도를 나타낸다. 그러나 기상 직후에 정확히 타액이 채취되지 않을 경우 기상 30분 후의 타액에서 측정한 코티졸 농도와의 차이가 나지 않는다. 이러한 결과는 최소 2.8nmol/L 정도의 차이가 있어야지 기상 직후에 정확히 타액이 채취되었다고 간주된다. 따라서 스크리닝 대상으로 포함된 여성들의 타액에서 먼저 코티졸을 정량 분석한 후, 기상 직후와 기상 후 30분에 채취한 시료에서 2.8nmol/L 이상 차이가 있는 시료만 선별하였다. 아울러 성기능이 내/외적 스트레스 요인에 의하여 영향을 받는바, 코티졸 농조가 극단적으로 낮거나 높아 부신기능에 이사이 있다고 판단되는 시료는 스크리닝 대상에서 제외하였다. Cortisol produced and secreted by the adrenal gland has a very pronounced circadian rhythm, especially at 30 minutes immediately after waking up. However, if saliva is not collected immediately after the weather, there is no difference from the cortisol concentration measured in the saliva 30 minutes after the weather. These results should be at least 2.8 nmol / L, which means that saliva was collected immediately after the weather. Therefore, after cortisol was quantitatively analyzed in the saliva of women included in the screening, only samples with a difference of more than 2.8 nmol / L were selected from samples taken immediately after the weather and 30 minutes after the weather. In addition, since sexual function is affected by internal and external stress factors, samples that are considered to have a shift in adrenal function due to extremely low or high cortisol concentration were excluded from screening.
그리고, 상기 채취한 타액 시료를 정제하였다.Then, the collected saliva sample was purified.
우선 1N NaOH를 각각 처리한 타액을, 80℃에서 약 20분동안 가열한 다음 얼음수조를 이용하여 급냉각시켰다. 그리고, 원심분리를 수행하여 타액에 포함되어 있는 소화효소, 박테리아 등을 제거하였다. 그 후, 상청액을 수거하여 1N HCl을 처리하여 pH를 중성산도로 맞추었다.First, saliva each treated with 1N NaOH was heated at 80 ° C. for about 20 minutes and then quenched using an ice bath. Then, centrifugation was performed to remove digestive enzymes, bacteria, and the like contained in saliva. The supernatant was then collected and treated with 1N HCl to adjust the pH to neutral acidity.
그리고, 여기에 뮤코당 분해효소 hyaluronidase type 1 (H 3506, Sigmaaldrich chemical co.) 500 IU를 처리하고 약 37℃ 에서 10분 동안 반응시켜 타액 내의 점액당단백질(뮤코당)을 분해하였다. 상기 시료를 80℃에서 약 10분 동안 가열한 다음 얼음수조를 이용하여 급냉각시켰다. 그 후, 원심분리에 의해 상기 변성된 점액당단백질 분해효소를 제거하였다.Then, the mucosaccharide degrading enzyme hyaluronidase type 1 (H 3506, Sigmaaldrich chemical co.) 500 IU was treated and reacted at about 37 ° C. for 10 minutes to decompose the mucus glycoprotein (mucosaccharide) in saliva. The sample was heated at 80 ° C. for about 10 minutes and then quenched using an ice bath. Thereafter, the denatured mucin glycoproteinase was removed by centrifugation.
마지막으로, 타액과 동일양의 0.2% 젤라틴을 포함하는 완충액을 섞어 타액 정제과정을 마무리하였다.Finally, the saliva purification process was completed by mixing saliva with a buffer containing 0.2% gelatin in the same amount.
상기 공정에 총 1시간 30분 정도가 소요되었다.The process took about 1 hour and 30 minutes in total.
비교예 1 : 기존 열처리에 의한 전처리와 본 발명에 의한 전처리의 경우 단백질양 변화 비교Comparative Example 1 Comparison of Protein Change in Pretreatment by Existing Heat Treatment and Pretreatment by the Present Invention
기존에 사용되던 방법과의 비교를 위해, 기존의 타액 전처리 방법에 의거하여 (Howard et al., 1989; Tamate et al., 1997), 타액에 포함되어 있는 객담 및 이물질을 원심분리하여 (3000g, 10분) 제거한 후 타액 시료를 56℃에서 2시간 가열한 후 상온 (25℃) 에 10분간 방치한 후, 원심분리 (3000g, 20분)하고 상층액을 취하였다. (소요시간 약 3시간). spectrophotometer (Beckman DU 800 UV/VIS)를 이용하여 280nm (A280) 흡광도를 측정하였다For comparison with conventional methods of saliva, centrifugation of sputum and foreign substances in saliva was carried out in accordance with the existing method of saliva pretreatment (Howard et al., 1989; Tamate et al., 1997). 10 minutes) After removal, the saliva sample was heated at 56 ° C. for 2 hours, and then allowed to stand at room temperature (25 ° C.) for 10 minutes, followed by centrifugation (3000 g, 20 minutes) to obtain a supernatant. (About 3 hours). Absorbance at 280 nm (A280) was measured using a spectrophotometer (Beckman DU 800 UV / VIS).
실시예 1의 본 발명의 방법으로 처리된 타액시료에 대하여도 spectrophotometer (Beckman DU 800 UV/VIS)를 이용하여 280nm (A280) 흡광도를 측정하였다. Saliva samples treated with the method of the present invention of Example 1 were also measured for absorbance at 280 nm (A280) using a spectrophotometer (Beckman DU 800 UV / VIS).
대조군으로는 전처리 않은 타액시료를 사용하였다.A pretreated saliva sample was used as a control.
그 결과를 도 1에 도시하였다.The results are shown in FIG.
도 1에 나타난 바와 같이, 전처리 하지않은 타액시료의 흡광도는 0.05664 0.0002 였으며, 기존 방법으로 전처리된 타액 시료의 흡광도는 0.3794 0.0006이었다. 본 발명의 방법으로 전처리된 타액시료의 흡굉도는 0.0361 00003이었다.As shown in FIG. 1, the absorbance of the untreated saliva sample was 0.05664 0.0002 and the absorbance of the previously treated saliva sample was 0.3794 0.0006. The absorbance of the saliva sample pretreated with the method of the present invention was 0.0361 00003.
Dunn's Multiple Comparison Test결과, 종래 방법과 본 발명의 방법으로 전처리된 시료는, 전치리하지 않은 시료에 비해 흡광도가 유의하게 떨어져 있음을 확인할 수 있었으며 (p < 0.05), 종래 방법과 본 발명의 방법 사이에는 유의한 차이가 없었다 (p>0.05). As a result of Dunn's Multiple Comparison Test, it was confirmed that the samples pretreated by the conventional method and the method of the present invention had a significantly lower absorbance than the non-pretreated samples (p <0.05). There was no significant difference (p> 0.05).
이는 종래 방법과 본 발명의 방법 모두 타액에 포함되어 있는 단백질계 물질을 제거하는 효과 있음을 의미하며 두 방법 간에 단백질계 물질 제거효과의 차이는 크지 않음을 의미한다. This means that both the conventional method and the method of the present invention have the effect of removing protein-based material contained in saliva, and the difference in protein-based material removal effect between the two methods is not significant.
비교예 2 : 종래 열처리에 의한 전처리와 본 발명에 의한 전처리의 경우 스테로이드 호르몬 손실율의 비교Comparative Example 2: Comparison of Steroid Hormone Loss Rate in Pretreatment by Conventional Heat Treatment and Pretreatment According to the Present Invention
56℃로 (2시간) 가열 후 원심분리하여 타액시료를 전처리하였을 때 (종래 방법)와 산도 (pH) 변화/뮤코당분해를 병용하여 타액시료를 전처리하였을 때 (본 발명 방법) 타액시료의 전처리과정 중 스테로이드 호르몬의 손실이 있는지를 확인하기 위하여 타액시료에 방사선 동위원소로 표지된 스테로이드 호르몬 (코티졸, 테스토스테론, 에스트라디올)을 약 5000 cpm을 각각 첨가한 후, 스테로이드 호르몬의 회수율을 조사하였다. When the saliva sample is pretreated by heating at 56 ° C (2 hours) and centrifuged (conventional method) and when the saliva sample is pretreated using a combination of acidity (pH) / mucosaccharide decomposition (method of the invention) Pretreatment of the saliva sample To determine whether there was a loss of steroid hormones during the course of the procedure, saliva samples were added with 5000 cpm of steroid hormones (cortisol, testosterone, estradiol) labeled with radioisotopes, and then the recovery rate of steroid hormones was examined.
그 결과를 도 2에 도시하였다.The results are shown in FIG.
Kruskal-Wallis test 결과, 종래 방법과 본 발명의 방법으로 타액 시료를 전처리 하였을 때 전처리 과정중 스테로이드 호르몬(코티졸, 테스토스테론, 에스트라디올)의 회수율에는 차이가 없었으며 (p > 0.05) 이들 두 과정 모두에서 스테로이드 호르몬의 회수율을 전처리하지 않은 타액시료의 회수율과 비교하여도 유의한 차이가 없었다 (p > 0.05). As a result of the Kruskal-Wallis test, there was no difference in the recovery rate of steroid hormones (cortisol, testosterone, estradiol) during the pretreatment when the saliva sample was pretreated with the conventional method and the method of the present invention (p> 0.05). There was no significant difference between the recovery of steroid hormones and the recovery of saliva samples without pretreatment (p> 0.05).
이는 두 과정 모두에서 스테로이드 손실은 크게 일어나지 않음을 의미한다. This means that steroid loss does not occur significantly in both processes.
비교예 3 : 종래 열처리에 의한 전처리와 본 발명에 의한 전처리의 경우 스테로이드 호르몬 검출의 정확성 비교Comparative Example 3 Comparison of Accuracy of Steroid Hormone Detection with Pretreatment by Conventional Heat Treatment and Pretreatment According to the Present Invention
상기와 같이, 단백질 변화량이나 스테로이드 손실율의 큰 차이가 없는 종래 방법과 본 발명의 방법이 실제, 스테로이드 호르몬의 정량 분석시 어떠한 정확성의 차이를 보이는지 알아보기 위해 방사면역측정법을 이용하여 스테로이드 호르몬을 검출하였다.As described above, steroid hormones were detected by radioimmunoassay to find out whether the conventional method and the method of the present invention have no significant difference in the amount of protein change or steroid loss rate. .
이를 위하여 타액시료를 1차 원심분리(3000g, 10분)하여 객담성분을 1차적으로 제거하였고, 상층액을 취하였다. 상층액에 Dextrane이 코팅된 활성탄 (dextran coated 0.1% activated charcoal (w/v))을 4℃로 유지되는 저온실에서 12시간동안 교반하여 타액시료내에 포함되어 있는 스테로이드 호르몬등 분자량이 작은 물질들을 제거하였다 (charcoal stripped saliva, CSS). For this purpose, the saliva sample was first centrifuged (3000 g, 10 minutes) to remove the sputum component first, and the supernatant was taken. Dextrane-coated activated carbon (dextran coated 0.1% activated charcoal (w / v)) in the supernatant was stirred for 12 hours in a low temperature chamber maintained at 4 ° C to remove small molecular weight substances such as steroid hormones contained in saliva samples. (charcoal stripped saliva, CSS).
이 CSS에 잔류 스테로이드 호르몬이 포함되어 있는지 RIA 방법으로 확인한 결과 CSS내에는 코티졸 및 성 호르몬이 포함되어 있지 않았다 (검출범위 이하).The RIA method confirmed that the CSS contained residual steroid hormones. The CSS did not contain cortisol and sex hormones (below detection range).
CSS에 기지농도(
Figure 65e3
知濃度)의 코티졸 (500 pg/100 ul), 테스토스테론 (50 pg/100 ul) 및 에스트라디올 (50 pg/100 ul)를 각각 첨가하여 종래 방법과 본 발명의 방법에 의한 타액시료 전처리 과정을 수행한 후 타액 시료내에 이들 스테로이드 호르몬을 각각 정량분석하였다.
Known concentration in CSS (
Figure 65e3
Pretreatment of saliva samples by the conventional method and the method of the present invention is carried out by adding cortisol (500 pg / 100 ul), testosterone (50 pg / 100 ul) and estradiol (50 pg / 100 ul), respectively. Each of these steroid hormones was then quantified in saliva samples.
그 결과를 이하 표 1에 기재하였다.The results are shown in Table 1 below.
표 1
전처리 과정 없음(pg/100 ul) 종래 방법(pg/100 ul) 본 발명 방법(pg/100 ul)
코티졸 첨가(500pg/100 ul) 595.5 ± 27.5 495.1 ± 43.9 537.2 ± 1.9
테스토스테론 첨가(50 pg/100ul) 65.2 ± 3.7 42.1 ± 2.5 48.1 ± 1.9
에스트라디올 첨가(50 pg/100ul) 56.2 ± 3.2 44.6 ± 2.3 47.9 ± 2.0
Table 1
No pretreatment (pg / 100 ul) Conventional Method (pg / 100 ul) Method of the Invention (pg / 100 ul)
Cortisol addition (500 pg / 100 ul) 595.5 ± 27.5 495.1 ± 43.9 537.2 ± 1.9
Testosterone addition (50 pg / 100ul) 65.2 ± 3.7 42.1 ± 2.5 48.1 ± 1.9
Add estradiol (50 pg / 100ul) 56.2 ± 3.2 44.6 ± 2.3 47.9 ± 2.0
표 1에서와 같이 전처리하지 않은 타액시료에서는 스테로이드 호르몬이 기대농도보다 다소 높게 검출되었다. 이는 타액시료내에 포함되어있는 활성탄으로 제거하지 못한 분자량이 큰 물질 (단백질, 뮤코당등)이 호르몬 정량분석시 항원-항체반응을 간섭한 효과로 해석되어 진다. As shown in Table 1, steroid hormones were detected slightly higher than expected in saliva samples that were not pretreated. This is interpreted as the effect that the high molecular weight substances (proteins, mucosaccharides, etc.) that could not be removed by activated carbon contained in the saliva sample interfered with the antigen-antibody reaction in hormonal quantitative analysis.
종래 방법에 의하여 전처리 된 타액시료에서는 코티졸을 제외한 성호르몬은 기대농도 보다 다소 낮게 검출되었고, 표준 오차값도 다소 크게 나와 정확성이나 반복성이 낮아 신뢰성이 높지 않음을 확인할 수 있었다. In the saliva sample pretreated by the conventional method, sex hormones except cortisol were detected slightly lower than expected concentration, and the standard error value was also slightly larger, indicating that reliability was not high due to low accuracy or repeatability.
이에 반하여, 본 발명의 방법의 경우 기대농도와 유의한 차이없이 스테로이드 호르몬이 검출되는 바, 본 발명의 방법은 검출농도의 정확성을 향상시켰음을 알 수 있다. On the contrary, in the case of the method of the present invention, steroid hormones are detected without significant difference from the expected concentration, it can be seen that the method of the present invention improves the accuracy of the detection concentration.
검출이 정확하지 못하면 정량분석의 시료로써 가치가 없으므로, 본 발명은 단백질 양의 변화와 스테로이드 호르몬 손실율의 차이가 없으면서 호르몬 추출의 정확성이 향상되는 기술인 것이다.If the detection is not accurate, there is no value as a sample of the quantitative analysis, the present invention is a technique that improves the accuracy of hormone extraction without the difference between the change in protein amount and steroid hormone loss rate.

Claims (16)

  1. 다음의 단계를 포함하는 타액 정제 방법: Saliva purification method comprising the following steps:
    (a) 채취한 타액에 pH 12~14의 강염기를 처리하는 단계;(a) treating the collected saliva with a strong base of pH 12-14;
    (b) 가열 후 냉각시키는 단계; (b) cooling after heating;
    (c) 중화 단계; 및(c) neutralization step; And
    (d) 점액당단백질(뮤코당) 제거단계.(d) mucus glycoprotein (mucosugar) removal step.
  2. 제1항에 있어서, 상기 방법은 스테로이드 호르몬의 정량분석을 위해 타액을 전처리하는 공정인 것을 특징으로 하는 타액 정제 방법.According to claim 1, The method is a saliva purification method, characterized in that the step of pretreatment saliva for quantitative analysis of steroid hormones.
  3. 제2항에 있어서 상기 스테로이드 호르몬은 성호르몬 또는 부신피질 호르몬인 것을 특징으로 하는 타액 정제 방법.The method of claim 2, wherein the steroid hormone is sex hormone or corticosteroid.
  4. 제1항에 있어서, 상기 (a)단계에서 pH 12~14의 강염기는 NaOH, LiOH, KOH, Ca(OH)2 로 구성된 군에서 선택되는 1종인 것을 특징으로 하는 방법.The method of claim 1, wherein the strong base having a pH of 12 to 14 in step (a) is one selected from the group consisting of NaOH, LiOH, KOH, Ca (OH) 2 .
  5. 제1항에 있어서, 상기 (b)단계에서 가열은 70~90℃의 온도로 이루어지는 것을 특징으로 하는 방법.The method of claim 1, wherein the heating in step (b) is characterized in that at a temperature of 70 ~ 90 ℃.
  6. 제1항에 있어서, 상기 (b)단계에서 냉각은 얼음수조를 이용하여 급냉시키는 것에 의해 이루어지는 것을 특징으로 하는 방법.The method of claim 1, wherein the cooling in step (b) is performed by quenching using an ice bath.
  7. 제1항에 있어서, 상기 (b) 단계 후, 원심분리에 의해 타액으로부터 소화효소 및 박테리아를 제거하는 단계를 추가로 포함하는 방법.The method of claim 1, further comprising, after step (b), removing digestive enzymes and bacteria from saliva by centrifugation.
  8. 제1항에 있어서, 상기 (c) 중화단계는 pH 1~2의 강산을 처리하는 것에 의해 수행되는 것을 특징으로 하는 방법.The method of claim 1, wherein the step (c) neutralization is carried out by treating a strong acid of pH 1-2.
  9. 제8항에 있어서, 상기 pH 1~2의 강산은 HCl, H2SO4, HNO3로 구성된 군에서 선택되는 1종인 것을 특징으로 하는 방법.The method of claim 8, wherein the strong acid having a pH of 1 to 2 is one selected from the group consisting of HCl, H 2 SO 4 , and HNO 3 .
  10. 제1항에 있어서, 상기 (d) 단계에서 점액당단백질(뮤코당) 제거는 점액당단백질(뮤코당) 분해효소를 처리하는 것에 의해 이루어지는 것을 특징으로 하는 방법.The method of claim 1, wherein in step (d), the mucus glycoprotein (mucosugar) removal is performed by treating the mucus glycoprotein (mucosaccharide) degrading enzyme.
  11. 제10항에 있어서, 상기 점액당단백질(뮤코당) 분해효소는 Nacetylhexosamine-[1→4] glycosidic bond를 분해하는 것을 특징으로 하는 방법.The method of claim 10, wherein the mucoglycoprotein (mucosaccharide) degrading enzyme is characterized in that to decompose Nacetylhexosamine- [1 → 4] glycosidic bond.
  12. 제1항에 있어서, 상기 (d) 단계에서 점액당단백질(뮤코당) 제거 후, 원심분리에 의해 점액당단백질(뮤코당) 분해효소를 제거하는 단계를 추가로 포함하는 방법.The method of claim 1, further comprising removing mucus glycoprotein (mucosaccharide) degrading enzyme by centrifugation after removing the mucus glycoprotein (mucosaccharide) in the step (d).
  13. 제12항에 있어서, 상기 점액당단백질(뮤코당) 분해효소를 제거 후, 완충액을 혼합하는 단계를 추가로 수행하는 것을 특징으로 하는 방법.The method of claim 12, further comprising the step of mixing the buffer after removing the mucoglycoprotein (mucosugar) degrading enzyme.
  14. 제13항에 있어서, 상기 완충액은 타액과 동일양의 젤라틴을 포함하는 것을 특징으로 하는 방법.The method of claim 13, wherein the buffer comprises the same amount of gelatin as saliva.
  15. 제1항에 있어서, 타액은 기상 후 1시간 이내에 채취하는 것을 특징으로 하는 방법.The method of claim 1 wherein saliva is collected within 1 hour after the weather.
  16. 제2항에 있어서, 스테로이드 호르몬의 정량분석은 방사면역측정법을 이용하는 것을 특징으로 하는 방법.The method of claim 2, wherein the quantitative analysis of steroid hormones uses radioimmunoassay.
PCT/KR2011/009639 2010-12-14 2011-12-14 Saliva purifying method WO2012081911A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2010-0127671 2010-12-14
KR1020100127671A KR20110068906A (en) 2009-12-15 2010-12-14 A method of diagnosing a menstrual activation using saliva
KR1020110133597A KR101467371B1 (en) 2010-12-14 2011-12-13 A Method of Purifying a Saliva
KR10-2011-0133597 2011-12-13

Publications (2)

Publication Number Publication Date
WO2012081911A2 true WO2012081911A2 (en) 2012-06-21
WO2012081911A3 WO2012081911A3 (en) 2012-09-07

Family

ID=46245226

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/009639 WO2012081911A2 (en) 2010-12-14 2011-12-14 Saliva purifying method

Country Status (1)

Country Link
WO (1) WO2012081911A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183170A1 (en) * 2002-09-09 2006-08-17 Gc Corporation Pretreatment kit for saliva and pretreatment method for saliva
JP2009085946A (en) * 2007-09-12 2009-04-23 Kao Corp Quantification method for steroid hormone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183170A1 (en) * 2002-09-09 2006-08-17 Gc Corporation Pretreatment kit for saliva and pretreatment method for saliva
JP2009085946A (en) * 2007-09-12 2009-04-23 Kao Corp Quantification method for steroid hormone

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AKUTSU, N. ET AL.: 'Measurement of estradiol levels insaliva collected from females in different menstrual phases and at different times of the day.' THE AUTONOMIC NERVOUS SYSTEMS vol. 42, 2005, *
YEHUDA, R. ET AL.: 'Relationship between 24-hour urinary-free cortisol excretion and salivary cortisol levels sampled from awakening to bedtime in healthy subjects.' LIFE SCIENCES vol. 73, 2003, *

Also Published As

Publication number Publication date
WO2012081911A3 (en) 2012-09-07

Similar Documents

Publication Publication Date Title
KR101467371B1 (en) A Method of Purifying a Saliva
SCHWEIKERT et al. Aromatization of androstenedione by cultured human fibroblasts
Zachmann et al. Steroid 17, 20‐desmolase deficiency: a new cause of male pseudohermaphroditism
Pincus The analysis of human urines for steroid substances
Brown et al. Cultured human skin fibroblasts: a model for the study of androgen action
KUTTENN et al. Androgen production and skin metabolism in hirsutism
Casey et al. Extraadrenal formation of a mineralocorticosteroid: deoxycorticosterone and deoxycorticosterone sulfate biosynthesis and metabolism
Colenbrander et al. Changes in serum testosterone concentrations in the male pig during development
Greaves et al. A guide to understanding the steroid pathway: new insights and diagnostic implications
Kellogg et al. Endogenous levels of 5 alpha-reduced progestins and androgens in fetal vs. adult rat brains
WO2015190792A1 (en) Method for diagnosing precocious puberty using saliva
Honour Steroid profiling
Gearhart et al. Androgen receptor levels and 5α-reductase activities in preputial skin and chordee tissue of boys with isolated hypospadias
Voss Saliva as a fluid for measurement of estriol levels
Attal-Khémis et al. Increased total 7α-hydroxy-dehydroepiandrosterone in serum of patients with Alzheimer's disease
Fonseca et al. Hormone replacement therapy increases ACTH/dehydroepiandrosterone sulfate in menopause
WO2012081911A2 (en) Saliva purifying method
KR20110068906A (en) A method of diagnosing a menstrual activation using saliva
Luppa et al. Variations of steroid hormone metabolites in serum and urine in polycystic ovary syndrome after nafarelin stimulation: evidence for an altered corticoid excretion
FINKELSTEIN Pregnanetriolone, an abnormal urinary steroid
Shackleton et al. Midgestational maternal urine steroid markers of fetal Smith–Lemli–Opitz (SLO) syndrome (7-dehydrocholesterol 7-reductase deficiency)
US6808932B1 (en) Diagnosis of Smith-Lemli-Optiz syndrome
Schuler Steroid sulfates in domestic mammals and laboratory rodents
Wen et al. Human granulosa-lutein cell in vitro production of progesterone, inhibin A, inhibin B, and activin A are dependent on follicular size and not the presence of the oocyte
Goudet et al. Steroidome and metabolome analysis in gilt saliva to identify potential biomarkers of boar effect receptivity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11849650

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC

122 Ep: pct application non-entry in european phase

Ref document number: 11849650

Country of ref document: EP

Kind code of ref document: A2